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A B S T R A C T
Background
Contracts are a verbal or written agreement that a patient makes with themselves, with healthcare practitioners, or with carers, where
participants commit to a set of behaviours related to the care of a patient. Contracts aim to improve the patients’ adherence to treatment
or health promotion programmes.
Objectives
To assess the effects of contracts between patients and healthcare practitioners on patients’ adherence to treatment, prevention and health
promotion activities, the stated health or behaviour aims in the contract, patient satisfaction or other relevant outcomes, including
health practitioner behaviour and views, health status, reported harms, costs, or denial of treatment as a result of the contract.
Search strategy
We searched: the Cochrane Consumers and Communication Review Group’s Specialised Register (inMay 2004); the Cochrane Central
Register of Controlled Trials (CENTRAL), (The Cochrane Library 2004, issue 1); MEDLINE 1966 to May 2004); EMBASE (1980
to May 2004); PsycINFO (1966 to May 2004); CINAHL (1982 to May 2004); Dissertation Abstracts. A: Humanities and Social
Sciences (1966 to May 2004); Sociological Abstracts (1963 to May 2004); UK National Research Register (2000 to May 2004); and
C2-SPECTR, Campbell Collaboration (1950 to May 2004).
Selection criteria
We included randomised controlled trials comparing the effects of contracts between healthcare practitioners and patients or their carers
on patient adherence, applied to diagnostic procedures, therapeutic regimens or any health promotion or illness prevention initiative
for patients. Contracts had to specify at least one activity to be observed and a commitment of adherence to it. We included trials
comparing contracts with routine care or any other intervention.
Data collection and analysis
Selection and quality assessment of trials were conducted independently by two review authors; single data extraction was checked by
a statistician. We present the data as a narrative summary, given the wide range of interventions, participants, settings and outcomes,
grouped by the health problem being addressed.
Main results
We included thirty trials, all conducted in high income countries, involving 4691 participants. Median sample size per group was 21.
We examined the quality of each trial against eight standard criteria, and all trials were inadequate in relation to three or more of these
standards. Trials evaluated contracts in addiction (10 trials), hypertension (4 trials), weight control (3 trials) and a variety of other areas
(13 trials). Sixteen trials reported at least one outcome that showed statistically significant differences favouring the contracts group,
five trials reported at least one outcome that showed differences favouring the control group and 26 trials reported at least one outcome
without differences between groups. Effects on adherence were not detected when measured over longer periods.
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Authors’ conclusions
There is limited evidence that contracts can potentially contribute to improving adherence, but there is insufficient evidence from large,
good quality studies to routinely recommend contracts for improving adherence to treatment or preventive health regimens.
P L A I N L A N G U A G E S U M M A R Y
Contracts between patients and healthcare practitioners for improving patients’ adherence to recommended healthcare activities
Sometimes patients do not complete a course of treatment or they do not follow recommended changes in diet or personal habits.
This poor adherence may be because treatments take a long time, have side effects or involve changing patients’ habits, which is often
difficult. Several interventions aim to change the relationship between patients and healthcare practitioners in order to improve the
patients’ adherence to treatments. One of these interventions is in the form of contracts between healthcare practitioners and patients,
by which one or both parties commit to a set of behaviours related to the care of the patient. Contracts may be written or verbal.
Most contracts are between healthcare practitioners and patients, but they may also occur between practitioners and carers, carers and
patients or by a patient with him/herself. In this review we assessed whether contracts between practitioners and patients really improve
the patients’ adherence to treatment or their health status. We also assessed the effects of contracts on other outcomes, including patient
participation and satisfaction, health practitioner behaviour and views, health status, harms, costs, and ethical issues.
We found 30 trials involving 4691 participants, examining several types of contracts. The main health problems targeted were substance
addictions, hypertension and overweight. Many of the trials were of poor quality and involved small numbers of people. Most were
conducted in the USA. In 16 of the trials there was at least one outcome showing statistically significant differences in favour of the
contracts group (although some of the improvements in adherence did not remain when measured after a longer period). In five trials
at least one outcome showed such differences in favour of the control group. In 26 trials there was at least one outcome for which there
was no difference between the contract and control groups.
There is not enough reliable evidence available to recommend the routine use of contracts in health services to improve patients’
adherence to healthcare activities or other outcomes.
B A C K G R O U N D
For many treatments and health promotion strategies, participants
need to take advantage of the advice, treatments and other ac-
tions offered by healthcare practitioners. A number of good stud-
ies and systematic reviews have evaluated interventions to improve
patients’ adherence to treatments (Haynes 2005; Rueda 2006).
Haynes, for example, reports that interventions to improve short-
term adherence to medications are relatively successful, but inter-
ventions for chronic conditions tend to be complex and not very
effective. One widely-used approach is a contract between health-
care practitioners and participants. We examine here the use of
contracts to improve adherence looking at the specific features of
contracts.
Definition and characteristics
Contracts are defined as a mutual agreement between two or more
parties that something shall be done by one or both (OED 2003).
As a behavioural strategy aiming at improving patients’ adherence,
contracts refer “to a process of specifying a set of rules regarding
some behaviour of interest and formalising a commitment to ad-
here to them” (Dunbar 1979). They are referred to as contracts,
behavioural contracts or contingency contracts. Contracts have
been used in a wide range of circumstances such as smoking ces-
sation, breast self examination, hypertension, diabetes, rheumatic
diseases, tuberculosis, hepatitis, for renal patients, and for people
with psychiatric conditions.
In the social science literature, there is no consistent definition of
contracts. This section aims to scope the features and concepts
underpinning the use of contracts in health and draws from a wide
range of research.
The following summarises the features of contracts when used as
a strategy to increase adherence:
• Formalisation. Contracts formalise the agreement of patients
and/or healthcare practitioners to follow treatment, prevention
or health promotion activities. These usually involve therapeu-
tic activities (particularly adherence to prescribed drugs) but
they also include: observance of appointments (Hayes 2000);
lifestyle behaviours, such as smoking cessation (Resnikow1997)
and nutrition habits (Boehm 1997); and diagnostic actions, like
breast self examination (Lierman 1994). Contracts are often
written, but some examples of verbal contracts exist (Anderson
1982; Arnet 2000).
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• Parties to the contract. Contracts are most often established
between patients and their physicians. There are examples of
other parties being involved, such as nurses andpatients (Boehm
1997), patients and selected partners from the household or the
community (Keane 1984; Lierman1994;Morisky 2001;Ossip-
Klein 1984), and even contracts with the patients themselves
(a self-commitment made explicit) (Brus 1998). We found one
study of a tripartite contract: between the patient, the healthcare
practitioner of a pain clinic and the primary care physician
(Fishman 2002a).
• Usually adults. In the literature, contracts primarily involve
adult patients, although adolescents (Morisky 2001; Wysocki
1989) and children (Greenan-Fowler 1987; Sherman 1991)
have also been involved. The role of children is particularly
delicate, since their decision capacity is limited and sometimes
delegated to their carers, and their right to have access to in-
formation entails specific requirements to ensure their compre-
hension (Sanz 2003).
Contingency contracts
When contracts include a reward conditioned by the accom-
plishment of the contract clauses, they are referred to as contin-
gency contracts: “a specifically negotiated agreement that provides
for the delivery of positive consequences contingent on desirable
behaviour” (Janz 1984). There are two main types of rewards
(Christiensen-S. 1985). ’Token economies’, which were initially
used as a behavioural therapy, are rewards from the healthcare prac-
titioner in the form of tokens that can be exchanged for something
of value (Hayes 2000; Wysocki 1989). Rewards may also involve
the refund of a deposit (’deposit contract’) (Chowdhury 1997;
Molteni 1983; Paxton 1983). One study reported a self-reward,
where the patient states what s/he will do to reward him/herself
(Neale 1991). Another study involved insurance refund policies
based on measures of treatment success (Harzer 2000). Neither
contingencies nor penalties seem to take place, however, if health-
care practitioners do not respect their terms in the contracts.
Ethical issues arise when access to treatment may be dependent
upon patients’ behaviour as specified in a contract (Biller 1999).
Contracts have been used not only as behavioural therapy, but
also to support decisions on the appropriateness of a given treat-
ment. For example, one study described how compliance with a
behavioural contract was used as a criterion to identify individ-
uals with the potential to maintain a transplanted organ capably
(Cupples 2001). The circumstances in which a patient can make
a rational and autonomous choice, in the context of contracting,
is also worthy of ethical consideration (Biller 1999).
For this review, contracts are defined as any type of agreement,
verbal or written, by which one or both parties agree to a set of
behaviours related to the care of a patient. Contracts may be es-
tablished between healthcare practitioners and patients, between
practitioners and carers, between carers and patients, or by a pa-
tient with him/herself. Contracts are intended to improve adher-
ence to treatment, prevention and health promotion activities.
Theoretical models
Concordance and the relationship model
Compliance or adherence has been defined as “the extent to which
a person’s behaviour (in terms of taking medications, following di-
ets or executing lifestyle changes) coincides with medical or health
advice” (Haynes 1979a). The increasing use of the term ’adher-
ence’ instead of ’compliance’ is due to the latter’s negative and
authoritarian connotations. Adherence implies the patient’s active
choice in following medical recommendations rather than passive
co-operation of obedience to them (Evangelista 2000). However,
adherence is still rooted in a medical model, in which patients
are expected to do what healthcare practitioners tell them. In this
review, we use the term adherence in its most restricted sense, to
designate the extent to which something that has been implicitly
or explicitly agreed between healthcare practitioners and patients
(for example, a treatment), actually happens, regardless of the type
of relationship between patients and practitioners.
The term ’concordance’ aims to reflect that patients/persons have
self-determination and control over what happens to them. Con-
cordance means shared decision making and arriving at an agree-
ment that respects patients’ wishes and beliefs (Jones 2003). It
has been argued that healthcare practitioners may also find that
patients’ difficulties in adhering to treatments - such as those ex-
perienced by chronically-ill patients with their treatments (for ex-
ample, taking treatments consistently whilst suffering side effects)
- may be minimised in the context of a concordant relationship
(Townsend 2003).
Some contracts depend on a relationship model. Contrary to the
assumptions in a concordant relationship, the healthcare practi-
tioner perspective predominates in the literature on behavioural
contracts scrutinised so far. References to healthcare practitioners’
obligations (like providing information or evidence-based treat-
ments) are generally missing. Contracts often appear not to be
based on a relationship marked by shared decision making, but
instead they place the responsibility of failing the terms of the
contract on the patients’ side. The literature around concordance
is particularly relevant since it provides a critical perspective to
understand the patient - provider relationship, whatever form it
takes (including contracts). With concordance, an essential com-
ponent in a shared decision-making model is that of mutual agree-
ment (implicit or explicit) with the treatment decision (Charles
1997). This kind of agreement may indeed reinforce the mutual
contribution of healthcare practitioners and patients to a success-
ful treatment (Maher 2003). Furthermore, it has been argued that
unless patients and doctors are collectively or jointly involved in
the decision-making process, sharing information and building up
consensus, there is no basis for reaching an agreement on which a
treatment can be implemented (Stevenson 2000). In a concordant
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consultation the patient and the healthcare professional partici-
pate as partners to reach that agreement (Cox 2004).
Impact on health
Lowadherencemay seriously compromise the effectiveness of ther-
apeutic regimens. It has been reported that adherence may be as
low as 10% in keeping appointments (number of appointments
kept in relation to the total number of appointments scheduled),
or may be between 40% and 60% in the case of adherence to
long-term medications (percentage of patients with presence of
medications in body fluids or self-assessed reporting of drug in-
take) (Sackett 1979). Poor adherence to treatment regimens has
been associated with a reduction in treatment effectiveness, lead-
ing to worse health outcomes and even death (Cleemput 2002;
Gordis 1979; Simpson 2006). The World Health Organization
(WHO) report on adherence documents worse outcomes associ-
ated with poor adherence for conditions like hypertension, type-
2 diabetes and depression (WHO 2003). There is some evidence
that the costs involved in treating non-adherent patients are greater
than those involved in treating adherent ones (Cleemput 2002;
Heinssen 1995). In the United Kingdom (UK), it has been esti-
mated that missed appointments resulted in an economic loss of
250 million pounds sterling per year (DPP 2003). However, ad-
herence to potentially harmful treatments may also lead to adverse
outcomes (Simpson 2006).
Advantages of contracts
What are the potential advantages of contracts over other inter-
ventions that seek to improve adherence and concordance? First,
they could allow for better replication if they are standardised
and do not include extensive training or educational components.
Contracts may be cheaper to implement than other combined or
more complex interventions, or even than supervised self-admin-
istration of drugs (Keane 1984). Apart from that, in a case study,
contracts have shown cost savings related to an increase in adher-
ence and the rationalisation of the care provided (Heinssen 1995).
For patients/participants, provided that the interventions used are
effective, the benefits include health gains, psychological comfort
(Jones 2003) and a better understanding of what they are expected
to do and why.
Evidence base for improving adherence
Haynes reviewed the factors associated with the level of adher-
ence to therapeutic regimens (Haynes 1979b). The type of dis-
ease seems to play a secondary role, except in specific conditions:
adherence tends to be lower in some psychiatric disorders such as
depression, for example. System or organisational issues such as
referral delays, waiting times and appointment schedules have a
stronger influence than the type of disease on the level of patients’
adherence. In relation to the features of the therapeutic regimens,
low adherence has been found almost constantly in treatments of
longer duration and involving several drugs. Socio-economic bar-
riers, side effects of treatments and denial of the illness have also
been related to poor adherence (Mellins 1992). Finally, the inter-
action between patients and healthcare practitioners is decisively
important in ensuring that what has been explicitly or implicitly
agreed, actually takes place. Effective communication of usage in-
structions for drugs, and the clinician’s understanding of patients’
concerns about their problems or treatment preferences, have been
associated with an increase in patients’ adherence and willingness
to participate (Hulka 1979).
Interventions to increase adherence may address organisational is-
sues, the simplification of therapeutic regimens, the interface be-
tween the patient and the healthcare practitioner, and patients’
behaviour. Strategies to increase adherence to regimens have been
systematically reviewed in general (Haynes 2005), and in rela-
tion to specific diseases, like tuberculosis (Volmink 2000; Volmink
2006), HIV/AIDS (Rueda 2006) or mental illness (Reda 2001),
reporting the effects of these interventions on patients’ adherence
and on other outcomes. These interventions tend to be complex.
Firstly, many different actors and activities may be involved. Edu-
cational interventions, for example, may involve physicians, other
therapists, facilitators, educational materials, and different sched-
ules and structures of the sessions. Secondly, some interventions
are a combination of different strategies, such as patient instruc-
tions combined with visits to a specialist, or patient brochures to-
gether with group sessions. This complexity makes it very difficult
to know which are the key elements that may have an impact on
patients’ adherence or on the improvement of health outcomes.
Results from these reviews indicate that some strategies or combi-
nation of strategies may improve adherence or health outcomes,
but their effects are not very remarkable overall when compared
with the effort they require (Haynes 2005).
While this review focuses on a single strategy in the context of any
health condition, several systematic reviews have assessed interven-
tions to improve adherence or compliance in relation to specific
conditions. Five included contracts. One was restricted to adher-
ence to appointment keeping, and considered only randomised
controlled trials written in English (Macharia 1992). Another as-
sessed controlled studies, published in English language journals,
of patients’ adherence to therapeutic regimes (Roter 1998). Three
other reviewswere published inTheCochrane Library.One of them
focused on tuberculosis (Volmink 2006), another on reminder
packaging (Heneghan 2006) and yet another considered adher-
ence to prescribed (self-administered) medications only (Haynes
2005). No systematic review has addressed contracts as a strategy
to improve patients’ adherence to any kind of treatment, preven-
tion or health promotion activity, regardless of the setting and the
condition or disease affecting the patients.
O B J E C T I V E S
To assess the effects of contracts between patients and healthcare
practitioners on patients’ adherence to treatment, prevention and
health promotion activities, the stated health or behaviour aims
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in the contract, patient satisfaction or other relevant outcomes,
including health practitioner behaviour and views, health status,
reported harms, costs, or denial of treatment as a result of the
contract.
C R I T E R I A F O R C O N S I D E R I N G
S T U D I E S F O R T H I S R E V I E W
Types of studies
Randomised controlled trials (RCTs).
After the initial publication of the protocol for this review, we
amended the selection criterion for studies (which formerly in-
cluded some study designs other than RCTs). Preliminary search-
ing indicated that the number of randomised controlled trials
potentially eligible for inclusion in this review was much larger
than previously anticipated, thereby removing the need to examine
studies providing less robust evidence. The ’Criteria for consider-
ing studies for this review / Types of studies’ section was amended
to include only RCTs (excluding quasi-randomised trials, con-
trolled before-and-after studies and interrupted time series analy-
ses).
Types of participants
Patients or their carers, of any gender and age, with any health con-
dition and in any health setting. The term ’patient’ is used broadly
to refer to any person undergoing diagnostic tests, or treatment,
or participating in any illness prevention or health promotion ini-
tiatives.
Practitioners, including clinicians, nurses and any worker or ser-
vice providing screening, diagnosis, therapeutics, rehabilitation,
prevention or health promotion activities.
Types of intervention
Contracts concerning treatment, prevention and health promo-
tion activities aimed at improving patients’ adherence. Contracts
included any verbal or written statement specifying at least one
treatment, prevention or health promotion activity to be observed,
and a commitment of adherence to it.
Contracts could take place between healthcare practitioners or ser-
vices and patients or their carers, between patients and their car-
ers, or between patients themselves (self-commitment). Contracts
could relate to any diagnostic procedure, therapeutic regimen, re-
habilitation measure, general health advice, referral instruction,
or any other activity or combination of activities involved in the
management of patients.
Explicit rewards (like tokens, cash or social benefits) may or may
not have been present. Self-management was included, providing
that self-management appears to be supported by any form of
contracting.
The control was any intervention (such as instructions, education,
incentives or reminders) or combination of interventions, aimed
at improving patients’ adherence; or no intervention. We excluded
studies comparing different modalities of contracts.
We included studies of multifaceted interventions provided that
a given modality of contract was present in the intervention but
not in the control group.
Types of outcome measures
Primary outcome
• Patients’ adherence or change in behaviour related to adherence
(e.g. patients’ adherence to treatment regime, to undergo a di-
agnostic procedure, to participate in a health promotion pro-
gramme, consistency with agreed targets, attendance, partici-
pation number and rates, length or duration of participation,
healthcare practitioners’ adherence to agreed specifications).
Secondary outcomes
• Patients’ participation in the contractual process (such as inclu-
sion of patients’ values and preferences) and degree of shared de-
cision making where alternative treatment options are present,
assessed through qualitative statements or scales.
• Outcomes of agreed aims stated in the contracts, both for pa-
tients and for healthcare practitioners.
• Patients’ satisfaction with the contracting process, assessed ei-
ther qualitatively or through scales. This includes satisfaction
with the level of knowledge about the healthcare process, reduc-
tion in the level of distress and other psychological outcomes
reported.
• Healthcare practitioners’ observance of contract terms and ap-
praisal of the contracting process.
• Health status measures: all outcomes consistent with, or rele-
vant to, the aims/specifications of contracts (e.g. for treatment,
prevention or health promotion, including mortality and mor-
bidity outcomes, improvement in the control of chronic con-
ditions and relief of symptoms).
• Harms associatedwith adhering to proposed treatment or health
promotion activity, (e.g. reported side effects, defaulted treat-
ment, and difficulties associated with maintaining treatment or
health promotion activities).
• Costs or savings incurred by patients, healthcare practitioners,
services or other institutions (e.g. insurance companies) derived
from adherence or non-adherence to healthcare activities.
• Denial or deferral of treatment.
• A post-hoc outcome related to the utilisation of health services
has been added, as it has been found in one of the trials and we
think it is relevant in this review.
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Although an association between adherence to drug therapy and
positive health outcomes has been shown (Simpson 2006), this
does not necessarily mean that good adherence to medication will
always predictably lead to better health outcomes (Haynes 2005).
However, we still think that it is of value to include studies with
only adherence-related outcomes, because certainly good adher-
ence may be a pre-requisite, although not the only one, for achiev-
ing good health outcomes.
S E A R C H M E T H O D S F O R
I D E N T I F I C A T I O N O F S T U D I E S
See: Cochrane Consumers and Communication Group methods
used in reviews.
We sought studies in any language regardless of their publication
status (published, unpublished, in press and in progress).
We searched the following electronic databases using specific
search terms in combination with the search strategy for
identifying trials, as detailed in Appendix 5b of the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2006):
• Cochrane Consumers and Communication Review Group’s
Specialised Register (in May 2004).
• The Cochrane Central Register of Controlled Trials
(CENTRAL) (The Cochrane Library 2004, issue 1) .
• MEDLINE (1966 to May 2004).
• EMBASE (1980 to May 2004).
• PsycINFO (1966 to May 2004).
• CINAHL (1982 to May 2004).
• Dissertation Abstracts. A: Humanities and Social Sciences
(1966 to May 2004).
• Sociological Abstracts (1963 to May 2004).
• UK National Research Register (2000 to May 2004).
• C2-SPECTR, Campbell Collaboration (1950 to May 2004).
We searched the reference lists of relevant studies identified by
the search.
The full search strategy for MEDLINE (Ovid) was as follows:
1 (contract or contracts or contracting).tw.
2 (agreement or agreements).tw.
3 (concord$ or negotiat$).tw.
4 (goal$ adj setting).tw.
5 or/1-4
6 patient compliance/
7 (compliance or comply or complying or complied).tw.
8 (adherence or adher or adhering or adhered).tw.
9 or/6-8
10 5 and 9
11 exp patient care planning/
12 (care plan$ or case plan$).tw.
13 case management.tw.
14 or/11-13
15 5 and 14
16 exp decision making/
17 (information adj3 shar$).tw.
18 exp professional patient relations/
19 exp consumer participation/
20 informed consent/
21 partnership.tw.
22 or/16-21
23 5 and 22
24 (behavioral adj3 contract$3).tw.
25 (behavioural adj3 contract$3).tw.
26 contingency contract$3.tw.
27 (contingent adj3 (contract$3 or intervention$ or
reinforcement)).tw.
28 participation deposit$1.tw.
29 ((refund$or reward$ or incentive$ or penalt$ or punish$)
adj5 contingent).tw.
30 ((refund$ or reward$ or incentive$ or penalt$ or punish$)
adj5 (contract$ or agree$ or
concord$)).tw.
31 monetary deposit.tw.
32 ((monetary or payment$ or voucher$ or token$) adj3
contingent).tw.
33 or/24-32
34 10 or 15 or 23 or 33
35 randomized controlled trial.pt.
36 controlled clinical trial.pt.
37 randomized controlled trials.sh.
38 random allocation.sh.
39 double blind method.sh.
40 single blind method.sh.
41 or/35-40
42 animals/ not (human/ and animal/)
43 41 not 42
44 clinical trial.pt.
45 exp clinical trials/
46 (clin$ adj25 trial$).ti,ab.
47 ((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or
mask$)).ti,ab.
48 placebos.sh
49 placebo$.ti,ab
50 random$.ti,ab.
51 research design.sh.
52 or/44-51
53 52 not 42
54 43 or 53
55 34 and 54
56 cohort studies/ or cohort.tw.
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57 (time adj series).tw.
58 (pre test or pretest or (post test or posttest)).tw.
59 or/56-58
60 34 and 59
61 55 or 60
M E T H O D S O F T H E R E V I E W
Study selection
One author (XBC) assessed the titles and abstracts of potentially-
relevant studies against the review inclusion criteria. If a study
could not be excluded on the basis of the title or abstract
alone, we obtained full papers. Two authors (XBC and KA)
assessed potentially-relevant papers for inclusion independently
against the review inclusion criteria. We resolved disagreements
through discussion and, if an agreement was not reached, referred
to a third author (PG). Reports were scrutinised for multiple
publication. We excluded potentially-relevant studies that did not
meet the inclusion criteria, giving the reasons for exclusion in
the table ’Characteristics of excluded studies’. We attempted to
contact some study authors for clarificationwhere informationwas
missing, but the age of some of the trials, together with authors’
resource constraints, meant that this was not always possible. We
aim to increase author contact for future updates of this review.
Assessment of methodological quality
Two authors (XBC and KA) assessed independently the quality of
studies (see criteria below). This process was not blind in relation
to the trial authors, their institutions and journals.
We used a form to guide the assessment of methodological quality,
and classified each quality component as ’adequate’, ’inadequate’
or ’unclear’. Disagreement was resolved by discussion with the
third author (PG).
The criteria applied to assess the methodological quality were as
follows:
(1) Method of randomisation: rated ’adequate’ if the method used
was described and the resulting sequences were unpredictable (e.g.
random numbers, drawing of lots or envelopes, tossing a coin);
rated ’inadequate’ if the sequences could be related to non-random
factors (e.g. record number, date of birth); rated ’unclear’ if the
descriptiondidnot allowus to judge themethodof randomisation.
(2) Concealment of allocation: rated ’adequate’ if participants
and investigators could not foresee the assignment (e.g. central
randomisation remote from trial location; sequentially numbered,
opaque, sealed envelopes); rated ’inadequate’ if participants and
investigators enrolling participants could foresee the upcoming
assignment (e.g. open allocation schedule; unsealed or non-opaque
envelopes); rated ’unclear’ if the description did not allow us
to judge allocation concealment. In the table ’Characteristics
of included studies’, allocation concealment was reported as:
adequate (A), unclear (B), inadequate (C), or that allocation
concealment was not used (D) as a criterion to assess validity
(Higgins 2006, chapter 6.3).
(3) Blinding of practitioners: rated ’adequate’ if it was reported that
practitioners or researchers (those offering the intervention) were
blind to who was in each group; rated ’inadequate’ if practitioners
or researchers knew the participants’ group, and this was stated
or could be clearly inferred from the text; rated ’unclear’ if the
description did not allow us to judge blinding of practitioners.
(4) Blinding of participants: rated ’adequate’ if participants did
not know to which group they belonged; rated ’inadequate’ if
participants knew to which group they belonged; rated ’unclear’ if
the description did not allow us to judge blinding of participants.
(5) Blinding in the assessment of outcomes: rated ’adequate’ if trial
authors explicitly stated that the primary outcome variables were
assessed blindly; rated ’inadequate’ if outcome(s) were not assessed
blindly; rated ’unclear’ if the description did not allow us to judge
blinding of outcome assessment.
(6) Baseline measurements: rated ’adequate’ if baseline
measurements were reported and there were no significant
differences between groups; rated ’inadequate’ if baseline
measurements were reported and there were significant differences
between groups; rated ’unclear’ if baseline measurements were not
reported.
(7) Loss to follow up: rated ’adequate’ if outcome measures
were explicitly obtained for 80% or more of professionals,
subjects, patients or episodes entering the study; rated ’inadequate’
if outcome measures were obtained for less than 80% of
professionals, subjects, patients or episodes entering the study;
rated ’unclear’ if it was not reported or it was impossible to
estimate.
(8) Consumer participation: rated ’adequate’ if there was
any mention of the involvement of consumers in the
design, implementation or interpretation of the research; rated
’inadequate’ if it was explicitly stated that consumers did not
participate in any stage; rated ’unclear’ if nothing was reported.
The assessment of methodological quality for each included study
is reported in Additional Table 01.
Data Extraction
Trials were distributed among two authors (XBC and KA)
for data extraction. The statistics editor and statistics assistant
of the Cochrane Consumers and Communication Group
checked the data extraction. Data extracted included the study
design, methods, participants, interventions, co-interventions
and outcomes. Data extracted to describe the modality of
contracts included: formalisation anddurationof contracts, parties
(categorised as practitioner, participant/patient, carer (including
peers and signficant others) and other), treatment, prevention and
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health promotion activities involved, and contingencies. We also
extracted data on the profile of trial participants.
We extracted the following data on outcomes (for all parties,
such as for children and parents): measures of adherence to
therapeutic regimens and use of services; adherence of healthcare
practitioners to the terms of the contracts; penalties and rewards;
quantitative measures or qualitative data describing the level of
shared decision making; measures of satisfaction with the process;
expectations and psychological distress; healthcare practitioners’
understanding and behaviour in relation to contracts; health status
data, such as improvement in clinical parameters or prognosis; cost
information, detailing (where possible) the way costs have been
estimated; and data on harms derived from the adherence or lack
of adherence to treatment/s.
Data Analysis
Where no intention-to-treat (ITT) analysis had been carried out,
we have tried to extract data to do it. Percentage loss to follow
up has been presented as reported, or calculated if the number
of selected individuals did not match the number of individuals
whose data has been analysed. For binary outcomes we recorded
the number of participants experiencing the event in each group
and calculated the odds ratios. For continuous outcomes we
extracted the arithmetic means and standard deviations (SD).
The main features of included studies have been presented in the
table ’Characteristics of included studies’, which also includes the
country, setting, health area or problem, recruitment mechanism,
sample size of participants randomised and main features of
contracts. Additional tables Table 02; Table 03; Table 04; Table
05 (one for each main group of health problems or areas)
describe the number of participants included in the analysis
(which may differ to the number of participants randomised), the
interventions, controls and outcomes. For each study, outcomes
have been placed in three columns depending on whether there
were statistically significant differences favouring the intervention
group, the control group or there were no differences, respectively.
Trials were all too diverse in terms of co-interventions, control
groups, features of contracts, outcomes and settings to try any
grouping by those criteria. Although the initial sub-group analyses
options included health status outcomes, presence and type of
contingencies, degree of shared decision making and type of
healthcare activity, we decided that the clearest way to group trials
was by health area, because slightly more than half of the included
trials could be grouped into three health areas (addictions,
hypertension, and weight control). The remaining trials examined
a range of conditions and are listed as ’miscellaneous’ in our
grouping. Data were presented by means of graphics only where
data were complete (numbers in all groups available for categorical
variables, and numbers in groups, means and standard deviations
for continuous variables).
Consumer participation
Given that this review was not limited to any particular
condition, we sought input from consumers or patients whose
health experiences were not restricted to a single disease
group and with experience or involvement in issues related to
the relationship between patients and healthcare practitioners.
Consumer participation was ensured in the protocol stage, and in
the development of the review, and will be taken into account in
future updates.
The protocol for this review, together with a user-friendly
questionnaire in electronic format to guide the process, was sent
to a number of consumers for comments. Feedback was received
from the following people and institutions: a social sciences
and gender specialist working as a Community Research and
Training Consultant, who is familiar with consumers’ points of
view (the Gender and Health Group, Liverpool School of Tropical
Medicine, Liverpool, UK), and theDirector ofDeveloping Patient
Partnerships (London, UK). The Cochrane Consumers and
Communication Review Group involved two other consumers
as external peer-reviewers of the protocol, and one consumer
as an external peer-reviewer of the review. Additionally, several
consumers involved in The Cochrane Collaboration provided
feedback directly to the review authors at both protocol and review
stages. Suggestions from consumers have been incorporated into
the protocol and review as much as possible.
D E S C R I P T I O N O F S T U D I E S
As a type of intervention designed to help shape the relationship
between patients, carers and practitioners, contracts are extremely
complex, poorly defined and described, and evaluated in many
different formats and ways. The lack of a consistent definition and
common features, and the variation in trials undertaken, meant
that we had to select one sensible way to present the results. The
table ’Characteristics of included studies’ offers a summary of the
following features of the included studies:
• study design;
• participants, including: country, setting, health problemor area,
method of recruitment, type of participants and number of
participants being randomised;
• Intervention, including characteristics of contract (form, par-
ties, type of incentives and existence of co-interventions) and
groups to which participants were allocated.
• outcomes.
We outline below themain elements of the studies included in this
review, in terms of the selection of studies; location and setting;
health problems addressed; participants; interventions and control
groups.
Search results and selection of included studies
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The search strategy retrieved a total of 4191 titles and abstracts.
Of those, 768 items were duplicates, 3348 were irrelevant, and
75 appeared to be relevant. Of those 75 that were potentially
relevant, we excluded 43 papers and included 32. Two pairs of
trials referred to the same trials presenting data from two different
follow-up periods: Piotrowski 1999 and Hartz 1999 being one
pair, and Calsyn 1994 and Saxon 1996 the other. The results of
these studies are reported under the study identifiers Piotrowski
1999 and Calsyn 1994, respectively. Schulman 1980 seemed to be
based in the same setting as Swain 1981, although it was unclear
whether the data analysed came from the same set of patients. For
the moment, we have reported the results as two trials but aim to
clarify this in the future. The final number of included trials is 30.
The dates of published trials ranged from 1973 to 2001.
All included studies were randomised controlled trials. Six of them
(20%) used modified randomisation techniques (stratified and
cluster randomisation).
Location (country and setting)
The studies were based in the USA (26), UK (2), Canada (1) and
Australia (1). The main settings of trials were:
• Specialised services (7): clinics specialising in providing care for
addictions, a geriatric centre and an optical centre;
• Primary health care (5);
• Hospital (2);
• Other settings (9) including specially set up programmes for
substance abuse, a weight loss programme for young girls and
other community based trials.
In seven (7) trials the setting could not be identified.
Health problems or areas
The included trials covered a wide range of health problems or
areas, including;
1. Addictions (10): these included alcohol (5 trials), smoking (3
trials) and opiates (2 trials);
2. Hypertension (4);
3. Weight control (3);
4. Miscellaneous (13) included: diabetes, tuberculosis, breast self
examination, healthy diet for the elderly, acne, depression, fear
desensitising, acute antibiotics treatment, eye care, rheumatoid
arthritis, and asthma.
Participants
Participants in all trials were people receiving care for a disease
or who were targets for preventive interventions. In 13 trials they
were recruited from the health system (patients receiving care, at-
tending ambulatory services or referred). Eleven trials recruited
participants using adverts, two trials used both methods, and an-
other trial recruited college students. The recruitmentmethodwas
not described in one trial.
The median number of participants per group was 21 (interquar-
tile range 24 subjects). All trial participants were adults except
in: Aragona 1975 (overweight children); Burkhart 2002 (children
with asthma);Wurtele 1980 (screening for tuberculosis) where the
age of participants ranged from 5 to 76 years; and Morisky 2001
(adolescents treated for latent tuberculosis, aged 11 to 19).
Fourteen trials (47%) compared two groups, eight trials (27%)
had three groups, five trials (17%) had four groups, one trial (3%)
had five groups and two (7%) trials had six groups.
Intervention: characteristics of contracts
Format
Contracts were written in 25 trials (83%), and in the other 5 trials
(17%) their format was not stated. Only four trial reports (13%)
included a sample of the contract form (Litzelman 1993; Morgan
1988; O’Farrell 1984; Ossip-Klein 1984).
Parties
Contracts were mainly established between two parties: between
participants or patients and healthcare practitioners in seven trials
(23%), between participants or patients and carers, peers or sig-
nificant others in nine trials (30%), and between healthcare prac-
titioners and carers in one trial (3%). In four trials (13%) con-
tracts were tripartite between patients, carers and healthcare prac-
titioners. Two trials (7%) examined a self-contract. In the other
seven trials (23%) the parties involved in the contracts were not
reported. See the ’Characteristics of included studies’ table for de-
tails on each particular trial.
Terms and incentives
Terms
The terms of the contracts included:
1. Stopping or reducing substance abuse (alcohol, opiates, tobacco)
(Calsyn 1994; Curry 1988; Piotrowski 1999; Poole 1981).
2. Posting a prompt calendar in a prominent location, plus at-
tending after care sessions and calling the alcohol programme in
advance if unable to attend (Ossip-Klein 1984).
3. Recording disulfiram (Antabuse) intake which was mailed to
the treatment programme monthly (Keane 1984).
4. Attending sessions (Brockway 1977; Lash 1998).
5. Keeping record of drinks and limiting alcohol intake (Vinson
2000).
6. Wives of participants observing and recording whether disulfi-
ram (Antabuse) was taken by their husbands, and in return they
avoid mentioning any fears of their husband’s future drinking,
with instructions on when to search for medical care (O’Farrell
1984).
7. Practicing muscular relaxation (Hoelscher 1986).
8. Exercising (Craighead 1989; Murphy 1982; Swain 1981).
9. Changing eating habits (Morgan 1988; Murphy 1982; Swain
1981).
10. Setting goals for children’s weight loss (Aragona 1975).
11. Working on a manual for phobia desensitising (Barrera 1977).
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12. Following written instructions for contact lens care, reasons
for care and goals for successful care (Claydon 1997).
13. Monitoring Peak Expiratory Flow Rate (PEFR) (Burkhart
2002).
14. Returning for tuberculosis skin-test reading (Wurtele 1980).
15. Reminding about breast self examination (BSE) (Mayer 1991).
16. Monitoring use of hands, and pain (Hammond 1999).
17. Taking medication (Flanders 1985, Morisky 2001, Putnam
1994).
18. Foot care behaviours (Litzelman 1993).
19. Following specified behaviours towards partners (McLean
1973).
One trial (3%) did not explicitly report the terms of the contract
(Binstock 1988).
Some of the contract terms included adherence to treatment (e.g.
return for tuberculosis skin-test reading). These are considered as
outcomes if they are presented as such in the studies, regardless of
whether they are also part of the contract’s terms.
Incentives
In 21 trials contracts had incentives attached to them, contingent
to the fulfillment of the contract terms. Incentives were of several
types:
• Five trials (17%) featured deposits. Participants delivered a
given amount of money to the researchers or healthcare prac-
titioners, which was then totally or partially reimbursed upon
completion of the terms of the contract (Aragona 1975; Brock-
way 1977; Craighead 1989; Mayer 1991; Poole 1981).
• Three trials (10%) incorporated tokens or goods, such as cash
credits to be exchanged for items that participants chose, or
selection of a gift (Flanders 1985; Murphy 1982; Piotrowski
1999).
• Other incentives were used in 13 trials (43%), as follows:
changes in methadone dosage (Calsyn 1994); special meals and
recreational activity (Ossip-Klein 1984); rewarding activities
(Barrera 1977; Hoelscher 1986); self-defined rewards (Binstock
1988; Burkhart 2002; Morgan 1988), change of partner be-
haviour (McLean 1973), praising and stickers (Burkhart 2002),
punishment of sending money to someone participants disliked
(Curry 1988), random reward (Flanders 1985) and unspecified
rewards (Hoelscher 1986; Putnam 1994; Swain 1981; Wurtele
1980).
Contracts in nine trials (30%) had no incentives attached to them.
Co-interventions
Twenty-five trials (83%) had co-interventions (some of them had
more than one). It was not always clear whether an intervention
was part of the contract arrangement, or was actually a co-inter-
vention. For example, the terms of the contract in Ossip-Klein
1984 included posting a prompt calendar to remember specific
tasks, but this reminder mechanism could also be seen as a co-
intervention. Co-interventions included:
• Counseling/education/instructions (18 trials): Aragona 1975;
Barrera 1977; Binstock 1988; Calsyn 1994; Claydon 1997;
Curry 1988; Craighead 1989; Haber 1993; Keane 1984; Lash
1998; Litzelman 1993; McLean 1973; Morgan 1988; Morisky
2001; Murphy 1982; Schulman 1980; Swain 1981; Vinson
2000.
• Training (skills or behaviours) (11 trials): Aragona 1975; Bin-
stock 1988; Brockway 1977; Burkhart 2002; Calsyn 1994;
Curry 1988; Hammond 1999; Hoelscher 1986; Mayer 1991;
O’Farrell 1984; Poole 1981.
• Reminders (4 trials): Burkhart 2002; Haber 1993; Mayer 1991;
Morgan 1988.
• Group support/treatment (2 trials): Calsyn 1994; Haber 1993.
• Monitoring or recording of medication taken, problems related
to taking medication (2 trials): Flanders 1985; Keane 1984.
• Goal setting (1 trial): Calsyn 1994.
Control groups
Control groups consisted of routine care in 14 trials (47%). Non-
routine control groups included the following interventions:
• Counseling/education/instructions (8 trials): Binstock 1988;
Calsyn 1994; Craighead 1989; Haber 1993; Keane 1984; Mor-
gan 1988; Morisky 2001; Swain 1981.
• Group support / treatment (5 trials): Curry 1988; Hoelscher
1986; Mayer 1991; Murphy 1982; O’Farrell 1984.
• Training (5 trials): Binstock 1988; Calsyn 1994; Curry 1988;
Hoelscher 1986; Poole 1981.
• Reminders (1 trial): Mayer 1991.
• Others (2 trials): cognitive re-structuring, role playing (Curry
1988); supervised exercise (Craighead 1989).
M E T H O D O L O G I C A L Q U A L I T Y
Eightmethodological quality criteria were applied to each trial (see
’Methods of the review / Assessment of methodological quality’,
for details). None of the trials met 5 or more of the 8 methodolog-
ical quality criteria; 1 trial met 4 criteria, 3 trials met 3 criteria, 6
met 2 criteria, 11 trials met a single criterion and the remaining 9
trials met none of the criteria. The assessment of methodological
quality for each included study is reported in Additional Table 01.
Method of randomisation and concealment of allocation
The randomisationmechanism to allocate participants into groups
was appropriately reported in three trials (Burkhart 2002; Curry
1988; Vinson 2000). In the other 27 trials it was not possible
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to determine the randomisation mechanism, although none gave
any evidence of utilising a quasi-experimental rather than truly
randomised study design.
Only two trials mentioned a method which allowed for conceal-
ment of allocation (Ossip-Klein 1984; Vinson 2000); in 28 trials
(94%) allocation concealment was unclear.
Baseline measurements
Baseline measurements were reported in 24 trials. No differences
in baseline measurements were reported in 16 trials, although only
9 of them showed baseline data. The other eight trials reported
some differences (six of them showing data).
Blinding
This behavioural intervention is difficult to blind to practitioners
andparticipants.Only four trials reported blinding of practitioners
or researchers (Litzelman 1993; Ossip-Klein 1984; Putnam 1994;
Swain 1981). In 22 trials blinding was not reported and in the
other 4 trials it was clearly stated that practitioners were not blind
to group allocation.
In 3 trials participants were blind to the allocated intervention
(Claydon 1997; Haber 1993; Hammond 1999), and the other 27
trials did not mention blinding of participants. In Claydon 1997,
it should be noted, patients were unaware of being participants in
a trial.
Blinded assessment of outcomes was reported in 6 trials (Claydon
1997; Hammond 1999; Hoelscher 1986; Litzelman 1993; Vinson
2000;Wurtele 1980). In 23 trials it was unclear, and1 trial reported
that outcome assessors were not blind to group allocation.
Follow up
Loss to follow up was less than 20% (rated as ’adequate’) in 19
trials, more than 20% (rated as ’inadequate’) in 4 trials, and could
not be determined in the other 7 trials.
Community or user involvement
None of the trials reported any participation of community mem-
bers or users in the design, implementation or interpretation of
the research, beyond the involvement expected from a behavioural
intervention.
Data on outcomes
Nine of the 30 trials provided enough data to estimate statistical
differences between groups (Craighead 1989, Lash 1998, Litzel-
man 1993, McLean 1973, Morisky 2001, Ossip-Klein 1984, Pi-
otrowski 1999, Poole 1981, Putnam 1994). The presentation of
numerical data was of poor quality: some statistical significances
were just mentioned in the text without P values; others had P
values but not the statistical parameter used (for example, F, t) or
their values; some did not show the number of subjects included
in the analyses of each group; and sometimes comparisons of more
than one intervention group were pulled together against more
than one control group pulled together as well.
Sample size
Sample sizes were generally small. The median sample size per
groupwas 21 (interquartile range 24), and only two trials hadmore
than 100 subjects in each group. With this very limited sample
size it is difficult to have the power to estimate relatively small
differences between groups.
R E S U L T S
The numerous outcomes were difficult to group in terms of their
meaning, methods of assessment and times of the assessments.
Therefore, it seemed impractical to attempt any pooling of data
for meta-analysis. However, for those outcomes where data were
complete (for example, standard deviations included when esti-
mating means, or the number of subjects included in the analyses
of each group) we entered data into RevMan Analyses and pro-
duced forest plots, as noted below.
Overall, 16 trials reported at least 1 outcome that showed statisti-
cally significant differences favouring the contracts group; 5 trials
reported at least one outcome that showed statistically significant
differences favouring the control group; and 26 trials reported
at least 1 outcome without statistically significant differences be-
tween groups.
We present a narrative summary below for each of the health areas.
Additional Table 02; Table 03; Table 04; and Table 05 present all
outcomes for each individual trial.
1. Addictions
Ten trials (in 12 reports) examined the effects of contracts in the
context of substance addictions (Brockway 1977; Calsyn 1994;
Curry 1988; Keane 1984; Lash 1998; O’Farrell 1984; Ossip-Klein
1984; Piotrowski 1999; Poole 1981; Vinson 2000). See also com-
parison 01, outcomes 01 to 07, and additional Table 02.
Adherence
Adherence was measured in three different ways: (i) period of time
abstinent (substance-free samples); (ii) proportion of participants
abstinent (substance-free samples); and (iii) adherence to attending
sessions (sensitisation sessions).
Substance abuse
(i) Period of time abstinent
In one trial (Calsyn 1994), people in the contract group were
abstinent for a longer period (asmeasured by positive urine analysis
at 9 weeks post-treatment) than people in the control group.
In another trial (Piotrowski 1999), the longest abstinent period
depended on the length of time participants were on treatment.
For participants on treatment for 30 or 60 days, there were no
statistically significant differences. For those participants with 90
to 180 days on treatment, the longest period abstinent was greater
in the contracts group. Finally, for all participants (regardless the
period of time they were on treatment), there were no statistically
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significant differences reported between groups for each individual
substance (benzodiazepines, alcohol, amphetamines, barbiturates,
cocaine and marijuana). (See comparison 01, outcome 04).
(ii) Proportion of participants abstinent
Calsyn 1994 reported the proportion of participants abstinent at
9 weeks and at 18months, measured by urine analysis. At 9 weeks,
the proportion of participants abstinent from opiates was signifi-
cantly higher in the intervention group, but there were no differ-
ences between groups for cocaine. At 18 months, a significantly
greater proportion of participants in the intervention group was
abstinent compared with the control group: (a) regardless of the
type of substance; (b) for cocaine, and; (c) for opiates. Detailed
data was only reported for the 18-month measurement point (see
comparison 01 outcome 01).
In Piotrowski 1999 the proportion of participants in the contracts
group that were abstinent after 120 days of treatment showed no
difference with control group (measured by substance-free sam-
ples). (See comparison 01, outcome 02).
(iii) Adherence to attending sessions
The percentage of participants present at sessions one to eight
showed statistically significant differences favouring the contracts
group for sessions one, three, four and six; but these differences
vanished for sessions two, five, seven and eight (Ossip-Klein 1984).
In another trial, the number of participants who attended at least
one aftercare group session, and the total number of aftercare ses-
sions attended, were both statistically significantly greater in the
contracts group (Lash 1998). (See comparison 01, outcomes 05
and 06).
Smoking
Contracts appeared to have little effect on participants’ abstinence
from smoking, when assessed in the included studies.
(i) Period of time abstinent
In one study (Poole 1981) the time remaining abstinent (measured
by self-reported daily cigarette consumption) was similar between
groups (measured at any time period from 1 week to 12 months).
(ii) Proportion of participants abstinent
In Curry 1988 the proportion of participants abstaining from
smoking at any period (from treatment up to more than three
months, measured by weekly self-reported cigarette consumption)
was also similar in both groups. In Brockway 1977 the participants
in the contracts group smoked significantly fewer cigarettes (mea-
sured by individual self-report) than people in the control group
at 6 months follow up. However this difference vanished at 12
months follow up. In Poole 1981 there was no difference between
participants in the control and contracts groups when cigarette
consumption was compared with baseline smoking, from 1 week
to 12 months follow up. (See comparison 01, outcome 07).
Secondary outcomes
There were no differences between groups in any of the trials in
the following outcomes: dispensation of medication, participants’
satisfaction, change in Alcohol Use Disorder Identification Test
(AUDIT, a score to screen for drinking problems) and costs of
treatments. (See comparison 01, outcome 02).
O’Farrell 1984 measured participants’ abilities to solve problems,
and their perceptions about the treatment programmes, but the
study did not report any statistical analysis nor enough data to be
analysed post hoc.
A new outcome, related to the use of services, which was not fore-
seen at the protocol stage, is reported here. Contracts significantly
increased the discharge rate of patients under methadone therapy
(Calsyn 1994), because contingency contracting in this study in-
cluded discharge for continuous positive urine analysis. In other
words, contracts were unable to keep patients under treatment,
however participants in the contracts group were statistically sig-
nificantly less months out of treatment before readmission (i.e.
they were readmitted more after a shorter period than participants
in the control group).
2. Hypertension
Four trials examined the effects of contracts on a variety of out-
comes, in the context of hypertension management (Binstock
1988; Hoelscher 1986; Schulman 1980; Swain 1981). (See also
Additional Table 03).
Adherence
Two trials reported adherence outcomes. Hoelscher 1986 exam-
ined the effects of contracts on relaxation practices. The ’group
relaxation’ (without contracts) group showed significantly better
adherence to the relaxation practices than the control group, which
itself showed better adherence than the ’group relaxation plus con-
tract’ group; that is, the group with contracts performed worst
in terms of adherence. In another study (Swain 1981), however,
fewer participants in the contracts group discontinued treatment,
compared with the control group.
Secondary outcomes
Two of the four trials reported blood pressure changes. Binstock
1988 did not find any difference between groups at one year follow
up. In Swain 1981, contracts statistically significantly improved
the diastolic blood pressure measured over four visits (specific time
periods not reported).
In Swain 1981, contracts significantly improved patients’ knowl-
edge about hypertension care issues. Participants’ views on health
care were examined in one trial (Schulman 1980) through the Ac-
tive Patient Orientation scores reported by patients (health profes-
sionals support patients’ motivations reinforcing their active par-
ticipation, illness-management is collaborative, clear instructions
and skills training). Patients under contracts rated their care signifi-
cantly higher in theActive PatientOrientation scores. InHoelscher
1986, the cost-effectiveness (improvement in blood pressure per
hour of therapist contact) in the ’contracts plus group relaxation’
group was significantly higher than in the ’individual relaxation’
group.
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3. Overweight
Three trials addressed contract interventions for overweight peo-
ple (Aragona 1975; Craighead 1989; Murphy 1982). (See also
comparison 02, outcomes 01 and 02, and Additional Table 04).
Adherence
None of the three trials reported adherence outcomes.
Secondary outcomes
In Aragona 1975 participants in the contracts group lost more
weight than those in the control groups, both at the end of treat-
ment (-11.3 pounds in the intervention group compared with -
9.5 and +0.5 pounds in the control groups), and at 8 weeks follow
up (-7.9 pounds in the intervention group compared with -5.0
and +3.6 pounds in the control groups).
In Craighead 1989 there were three groups: contracts, supervised
exercise and minimal contact. Outcomes were measured at 12
weeks and 12 months. When data from the contracts and super-
vised exercise groups were pooled, people in these groups lost sig-
nificantly more weight than those in the minimal care group. For
those participants who completed the treatments, mean weight
losses were respectively 8.1 pounds (contracts), 11 pounds (su-
pervised exercise) and 4.6 pounds (minimal contact) (P < 0.05).
For longer term follow-up (12 months), mean weight losses were
4.3 pounds (contracts), 10.6 pounds (supervised exercise) and 4.2
pounds (minimal contact) (P < 0.05). (See also comparison 02).
Craighead 1989 also collected data on the self-reported helpful-
ness of the treatment: for this outcome there were no statistically
significant differences between the contracts group and the super-
vised exercise group.
In Murphy 1982 there were no statistically significant differences
in any of the outcomes: mean weight loss, percentage of excess
weight loss and weight reduction index.
4. Miscellaneous
Thirteen other studies covered a wide variety of health problems
or areas, and were included in the miscellaneous category: Barrera
1977; Burkhart 2002; Claydon 1997; Flanders 1985;Haber 1993;
Hammond 1999; Litzelman 1993; Mayer 1991; McLean 1973;
Morgan 1988; Morisky 2001; Putnam 1994; Wurtele 1980. (See
also Additional Table 05).
Acne
Flanders 1985 looked at the effects of contingent and non-contin-
gent contracting on compliance with acne treatment and number
of acne lesions. There was no difference in either of these outcomes
between contract and control groups. (See also additional Table
05).
Acute bacterial infections
Putnam 1994 assessed the effects of ’self-commitment’ on the ad-
herence to antibiotic treatment (score based on pill count) in pa-
tients suffering from acute bacterial infections. Adherence was sig-
nificantly better in the ’self-commitment’ group than in the con-
trol group. There were no differences between groups, however,
in self-reported adherence, nor in the number of additional pre-
scriptions required to finalise the treatment. (See comparison 06,
outcome 01 and Additional Table 05).
Arthritis
Hammond 1999 examined the effects of a joint protection pro-
gramme together with a contract on adherence to joint protection
(Joint Protection Behaviour Assessment-score measuring whether
twenty routine daily life tasks are performed correctly in order not
to cause joint damage) and to goals set in the joint protection pro-
gramme (self-reported joint protection homework), both showing
statistically significant improvements in the intervention group.
This effect was not observed in the second phase of the cross-over
trial. There were no differences between groups in knowledge or
health-related outcomes. (See also additional Table 05).
Asthma
A trial assessing a tripartite contractual approach (patients, prac-
titioners and parents) for monitoring Peak Expiratory Flow rate
(PEFR) in asthmatic children (Burkhart 2002) did not show any
differences between groups in adherence to PEFRmonitoring, nor
in the number of asthma episodes. (See also additional Table 05).
Breast self examination
One trial (Mayer 1991) looked at the effects of contracts between
female volunteers and healthcare practitioners on adherence to
breast self examination.Nodifferences were found between groups
in relation to either the frequency of breast self examination, or the
frequency of prompts by women’s partners. (See also additional
Table 05).
Contact lens care
Claydon 1997 examined the effects of a combined intervention
consisting of contracts, teaching materials (posters, video) and
reminders, on behaviours to take care of contact lenses, against
routine care. There were no differences between groups in any of
the targeted behaviours. (See also additional Table 05).
Depression
McLean 1973 evaluated the effects of contracts and training in
social learning principles on changing patients and their partners’
behaviours. Participants in the contract group, compared with
those receiving routine care, showed significant improvement of
targeted behaviours until 3 months follow up, as well as a decrease
in negative reactions at the time the treatment ended. (See com-
parison 05, outcome 01, and additional Table 05).
Diabetes
Litzelman 1993 and Morgan 1988 examined the effects of con-
tracts on the prevention of lower extremities abnormalities (mus-
culoskeletal and dermatological) associated with diabetes, and on
the treatment of type-II diabetes, respectively.Outcomes in Litzel-
man 1993 included adherence outcomes (for example, washing
the feet), health outcomes (for example, presence of foot lesions),
and physician practice outcomes (for example, documentation of
clinical observations). Some items in all three categories showed
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statistically significant improvements in the contracts groups (for
example, reduction of serious foot lesions, of dry or cracked skin,
washing the feet, inspecting the shoes), and in some other out-
comes there were no differences between groups. (See comparison
03, outcome 01). Knowledge of diabetes and its care statistically
significantly improved in the control group (Morgan 1988), while
in the same trial weight loss, reduction of fasting blood glucose and
glycosylated haemoglobin were not statistically different between
groups (the sample size, both groups combined, was 60. Knowl-
edge was measured with the Diabetic Knowledge Scale (DIAKS),
a 60-item scale developed and tested for this study. (See also com-
parison 03, outcome 01, and Additional Table 05).
Phobia
The contracts intervention in Barrera 1977 aimed at reducing
participants’ phobia about snakes. The control group completed
significantly more desensitisation sessions, and took more time to
study the programme materials. At post-test and follow-up there
was no benefit in any outcome compared with self-administered
systematic desensitisation. (See also additional Table 05).
Promotion of healthy diet and exercise
Another trial (Haber 1993) examined the effects of a combined
intervention, including contracts, to reduce the amount of specific
dietary components (and to improve other health behaviours such
as exercise and stress management). The contracts group showed a
statistically significant increase in fibre and decrease in salt intake,
but showed no differences compared with the control group in
intake of fats and sweets, and on the use of stress management
techniques or practice of flexibility exercises. (See also additional
Table 05).
Tuberculosis
Two trials related to tuberculosis adherence: one to returning for
the skin test reading (Wurtele 1980), which improved significantly
in the intervention group; and the other examined adherence to
medication regimen (Morisky 2001), which showed no differences
between groups. (See also comparison 04, outcome 01, and addi-
tional Table 05).
None of the included studies reported any of the following out-
comes: outcomes related to the contracts’ contingencies, harms,
or ethical issues.
D I S C U S S I O N
In this review we included 30 trials presented in 32 reports, the
majority set in the USA and all of them in high income countries.
The trials were undertaken in a range of settings (including some
projects and services that were established especially for research
purposes), and covered a wide range of health problems or areas,
contract forms, participants, and outcomes.
Most of the trials were of poor design, or were poorly reported,
or both. For example, only three trials reported their method of
randomisation and only two mentioned a method of randomisa-
tion which allowed for the concealment of group allocation. Poor
quality trials are more likely to be subject to bias and therefore the
results are less reliable than those from better quality trials (Schulz
1995). In addition, the sample size of many trials was small. Over
half the trials had more than two comparison groups, making
group sample sizes even smaller. Small trials are more likely than
larger trials to be insufficiently powered to detect statistically sig-
nificant differences between groups.
In 25 of the included trials, the intervention groups involved in the
contracting process also received other interventions intended to
improve the measured outcomes. In addition, in 16 of the trials, 1
or more control groups received interventions other than routine
care. It is therefore impossible, in most of the trials, to assess the
effects of contracts per se compared to routine care; an assessment
which would be very relevant for policy makers and consumers.
Contracts were described in varying degrees of detail, but they
hardly met all assumptions as described by Quill (Quill 1983):
terms and conditions explicitly stated; parties have unique re-
sponsibilities; the relationship between practitioners and patients
is consensual, not obligatory; and all parties are able to negoti-
ate. Furthermore, in the concordance paradigm (Jones 2003) con-
tracts should not be simply understood as a way to engage patients
to comply with a predefined set of instructions, but rather as a
strategy to involve patients into a shared decision-making process
(Charles 1997). The requirements for shared decision making -
such as mechanisms for patients’ preferences to be taken into ac-
count, information sharing and commondecision on the regimens
to follow - were even more difficult to find in the included trials.
The great variety of health problems or areas, participants, inter-
ventions, control groups and outcomes precluded any attempt to
pool data for meta-analysis. The areas with the largest number of
trials were those of substance addictions and hypertension. The
data presented in the graphs has to be interpreted with caution,
because we only included trials and outcomes with complete sets
of data. Apart from one trial on adherence to antibiotic regimens
for acute bacterial infections (Putnam 1994), all trials were related
to chronic conditions.
Four of the seven trials dealing with alcohol or opiate addictions
reported statistically significant differences in several outcomes
favouring the contracts group. The findings in the review byMiller
(Miller 2002) placed behavioural contracts as one of the top 10
(out of 46) treatment modalities for alcohol abuse (although im-
portant publication bias could not be ruled out in that review).
However, some of those positive effects seen in our review were
not consistent in all repeated measures over time. We could not
identify any trial addressing the effects of opioid contracts in the
management of opioids for the relief of chronic pain; contracts
which are widely used but of doubtful efficacy (Fishman 1999).
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In the area of smoking cessation (evaluated in three trials), our
findings seem to agreewith those in a review examining another be-
havioural intervention, namely competitions and incentives (Hey
2005): studies were underpowered and of variable quality. Further-
more, neither incentives, nor competitions, nor contracts, seemed
to enhance long-term cessation rates. In this review, the only pos-
itive effect reported (mean number of cigarettes smoked at several
periods in time; Brockway 1977) vanished when measured at 12
months follow up.
All three trials about hypertension that reported blood pressure
outcomes showednodifferences between groups onbloodpressure
measurements (except for better diastolic blood pressure in the
contracts group in Swain 1981). Adherence outcomes were both
better (Swain 1981) and worse (Hoelscher 1986) in the contracts
groups compared with the controls. Contracts in the context of
hypertension seem relatively unexplored, despite the fact that in
many countries blood pressure control falls far short of treatment
goals and the recognised relevance of behavioural interventions
to achieve those goals (Reunion 2006). The evidence from the
included trials supporting the use of contracts for hypertension
was very weak.
The external validity of the findings in the included trials is very
limited, due to several factors: their narrow geographical scope; the
settings which were specially established for research purposes in
most cases; the ways that participants were recruited (for example,
by advertisements); and the complexity and variety of contracts,
co-interventions and control group conditions, together with the
inconsistent descriptions of those interventions. All these features
discouraged any attempt to conduct a sub-group analysis, since
it would not be possible to control for each one of those factors.
In many cases it is difficult, if not impossible, therefore, to at-
tribute the effects seen to the impact of contracts alone. Further-
more, in many trials the selection criteria for participants were
very stringent. It seems unlikely that the findings of these trials can
be extrapolated to complex real situations as seen, for example, in
young black men of deprived communities in whom depression,
substance use (alcohol, tobacco and others), poor adherence and
poor blood pressure outcomes have all been identified as related
(Kim 2003).
There are some other critical factors to consider when deciding
whether to introduce contracting within a healthcare delivery sys-
tem. The included trials have addressed these factors little, if at all,
namely: acceptability of contracts to healthcare practitioners; par-
ticipants’, patients’ and carers’ satisfaction; costs; clinicians’ liabil-
ity, perpetuation of stigma in patients (Fishman 2002b); and eth-
ical considerations, especially where receiving treatment depends
on patients adhering to the terms of the contract, or where finan-
cial rewards are used. Some of the outcomes listed in the protocol
for this review addressed issues such as patients’ participation in
the contractual process, degree of shared decision making, harms
or ethical issues; but none of the trials reported data on them.
The lack of reporting on consumer participation highlights the
provider-centred approach, by which adherence is mainly seen as
a patient’s duty and practitioners remain in a patronising role; far
from the concordance model. This may be partially due to the
fact that most of the trials were conducted more than one decade
ago. Future studies should also address the issue of harms. We saw
in Hoelscher 1986 that the contracts group performed worse in
adhering to relaxation practices. But contracts might also reduce
the retention rate of patients, or affect the sincerity with which
patients report events that may breach the terms of the contract.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Contracts have been used as one among many other interventions
for improving adherence.
• Trials testing this intervention are generally small, and for many
the quality is uncertain.
• Some trials have demonstrated a positive effect of forming a con-
tract in certain situations (for example, substance addiction),
particularly when combined with other interventions, although
it may be ineffective or harmful in other situations.
• There is not enough evidence to recommend the widespread
introduction of patient contracts into health services.
Implications for research
Existing small trials suggest that contracts may have a positive ef-
fect. This needs further evaluation with large, good quality ran-
domised controlled trials to assess the effectiveness of patient con-
tracts within established health systems. These should be:
• designed to allow the effects of contracts and any co-interven-
tions to be assessed separately, as well as in combination where
appropriate, taking into account the different features of con-
tracts.
• undertaken in health fields where adherence is particularly im-
portant or problematic, and where patients and/or carers think
they may be valuable.
• undertaken in a range of settings where they might be imple-
mented if proven effective.
• designed to assess potential harms.
Reports of these trials should use a standard definition of contract
and describe the contract and contracting process in detail, includ-
ing the practitioner-patient relationship model and the extent of
consumers’ participation in the whole process.
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N O T E S
CHANGES FROM PROTOCOL
INCLUSION CRITERIA: the published protocol included
quasi-randomised trials, controlled before-and-after studies
(CBAs) and interrupted time series (ITS) analyses. As more RCT’s
than expected were found on searching, we subsequently decided
to include only RCTs.
OUTCOMES: We added “Utilisation of health services” in the
review as this was found in one of the studies and seems relevant.
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T A B L E S
Characteristics of included studies
Study Aragona 1975
Methods Randomised controlled trial with three groups.
Participants Country: USA.
Setting: other.
Health problem: overweight.
Recruitment: health system and adverts.
Participants: girls aged 5 to 11 who were overweight (n=15).
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Characteristics of included studies (Continued )
Interventions Contract features
- Form: written;
- Parties: practitioners-carers;
- Incentives: deposit;
- Co-interventions: yes.
Group 1: Contracts between parents and the providers of a weight loss programme. Parents gave a monetary
deposit to the programme and received money back when their children achieved an agreed weight loss.
Group 2: As per group 1, but parents also contracted to facilitate their child’s weight loss by carrying out
reinforcement techniques.
Group 3: No contracts.
Outcomes Mean weight change (pounds) from start of treatment to end of treatment, and to 8 week follow-up.
Notes
Allocation concealment B – Unclear
Study Barrera 1977
Methods Randomised controlled trial with three groups.
Participants Country: USA.
Setting: NA.
Health problem: snake phobia.
Recruitment: adverts.
Participants: adults (n=24).
Interventions Contract features:
- Form: written;
- Parties: NA;
- Incentives: other;
- Co-interventions: yes.
Group 1: Self administered desensitisation workbook.
Group2: Self administered desensitisationworkbookwith contract to reward self for completionofworkbook.
Group 3: Placebo.
Outcomes Number of desensitisation sessions attended; time spent studying materials.
Notes
Allocation concealment B – Unclear
Study Binstock 1988
Methods Randomised controlled trial with five different groups; two with contracts and three without.
Participants Country: USA.
Setting: PHC.
Health problem: hypertension.
Recruitment: health system.
Participants: adults (n=112).
Interventions Contract features:
- Form: written;
- Parties: NA;
- Incentives: other;
- Co-interventions: yes.
Group 1: Self-reward compliance contracts + educational program.
Group 2: Self-reward compliance contracts + educational programme + BPmeasurement at home + calendar
pills.
Group 3: Bi-monthly educational program.
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Characteristics of included studies (Continued )
Group 4: Educational + BP measurement at home.
Group 5: Calendar pills.
Outcomes Change of blood pressure from baseline to 1 year follow up.
Notes
Allocation concealment B – Unclear
Study Brockway 1977
Methods Randomised controlled trial with two groups.
Participants Country: USA.
Setting: speciality.
Health problem: addictions (smoking).
Recruitment: adverts.
Participants: adults (n=27).
Interventions Contract features:
- Form: NA;
- Parties: patients-practitioners;
- Incentives: deposit;
- Co-interventions: yes.
Experimental group: smoking cessation programme including contingency contracting (return of deposit
based on attendance at meetings and completion of assignments).
Control group: waiting list.
Outcomes Mean number of cigarettes smoked.
Notes
Allocation concealment B – Unclear
Study Burkhart 2002
Methods Randomised controlled trial with two groups.
Participants Country: USA.
Setting: NA.
Health problem: asthma.
Recruitment: health system.
Participants: children (n=42).
Interventions Contract features:
- Form: written;
- Parties: tripartite;
- Incentives: other;
- Co-interventions: yes.
Group 1: Contingency management (child contracted with parents and investigator to record daily peak
expiratory flow rate (PEFR)).
Group 2: Usual care.
Outcomes Adherence to PEFR monitoring over a 5 week period.
Notes
Allocation concealment B – Unclear
Study Calsyn 1994
Methods Randomised controlled trial with six groups.
Participants Country: USA.
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Characteristics of included studies (Continued )
Setting: NA.
Health problem: addictions (opiate).
Recruitment: health system.
Participants: adult patients (n=353).
Interventions Contract features:
- Form: written;
- Parties: patients-practitioners;
- Incentives: other;
- Co-interventions: yes.
Three of the groups (Groups 1 to 3) included contingency contracting - treatment depending on reaching
goals for abstinence from illicit drugs.
Group 1: Medication only: saw counsellor to complete standard treatment.
Group 2: Standard: counselling sessions and optional drug education classes.
Group 3: Enhanced: as per Group 2 plus relapse prevention skill training group and weekly group treatment
Groups 4, 5 and 6 mirrored the above groups but without the use of contingency contracts.
Outcomes Rates of illicit drug and alcohol use, discharge rates and length of time to readmission for those discharged.
Notes
Allocation concealment B – Unclear
Study Claydon 1997
Methods Randomised controlled trial with two groups.
Participants Country: UK
Setting: speciality.
Health problem: contact lenses.
Recruitment: NA.
Participants: contact lens wearers (n=80).
Interventions Contract features:
- Form: written;
- Parties: patients-practitioners;
- Incentives: none;
- Co-interventions: yes.
Group 1: Teaching programme on contact lens care, including contract to sign.
Group 2: Usual care.
All participants received a free supply of contact lenses for a year.
Outcomes Self reported contact lens care behaviours.
Notes Participants were unaware of being in a trial.
Allocation concealment B – Unclear
Study Craighead 1989
Methods Randomised controlled trial with three groups.
Participants Country: USA
Setting: other.
Health problem: overweight.
Recruitment: adverts.
Participants: women aged 18 to 30 and 15 to 45 pounds overweight (n=62).
Interventions Contract features:
- Form: written;
- Parties: NA;
- Incentives: deposit;
- Co-interventions: yes.
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Characteristics of included studies (Continued )
Group 1: Contracted exercise and written lessons.
Group 2: Instructions and supervised exercise.
Group 3: Instructions and minimal contact.
Outcomes Weight loss and Harvard Step Test fitness score at follow-up.
Notes
Allocation concealment B – Unclear
Study Curry 1988
Methods Randomised controlled trial with four groups.
Participants Country: USA.
Setting: other.
Health problem: addictions (smoking).
Recruitment: adverts.
Participants: adult smokers (n=139).
Interventions Contract features:
- Form: written;
- Parties: NA;
- Incentives: other;
- Co-interventions: yes.
Two different smoking cessation programmes, one of which included contingency contracting. Both pro-
grammes were subdivided into self-help and group support groups. Participants with contracts contracted to
send $15 to a person or organisation they disliked if they smoked after their quit date.
Outcomes Abstinence rates at 3, 6 and 9 months after treatment.
Notes
Allocation concealment B – Unclear
Study Flanders 1985
Methods Randomised controlled trial with four groups.
Participants Country: USA.
Setting: NA.
Health problem: acne.
Recruitment: other (screened as part of a larger study).
Participants: college students (n=42).
Interventions Contract features:
- Form: written;
- Parties: NA;
- Incentives: tokens;
- Co-interventions: yes.
Group 1: Non-contingent contract (agreement to return self-monitoring cards) with education and self
monitoring medication card.
Group 2: Contingent contract (agreement to return self-monitoring cards with chance to win prizes for each
returned) with education and self monitoring medication card.
Group 3: Education and self-monitoring card.
Group 4: Waiting list.
Outcomes Acne cream compliance rate and number of acne lesions.
Notes
Allocation concealment B – Unclear
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Characteristics of included studies (Continued )
Study Haber 1993
Methods Randomised controlled trial with two groups.
Participants Country: USA.
Setting: speciality.
Health problem: healthy diet.
Recruitment: adverts.
Participants: adults over the age of 55 (n=64).
Interventions Contract features:
- Form: NA;
- Parties: NA;
- Incentives: none;
- Co-interventions: yes.
Experimental group: health education sessions plus peer group support sessions where behaviour changes
were agreed through group discussion and participants signed a contract to undertake these changes.
Control group: received health education classes only.
Outcomes Change in consumption of salt, sweets, fat and fibre. Practising of relaxation techniques and bodymovements.
Notes
Allocation concealment B – Unclear
Study Hammond 1999
Methods Randomised controlled cross-over trial.
Participants Country: USA.
Setting: NA.
Health problem: arthritis.
Recruitment: health system.
Participants: adults (n=35).
Interventions Contract features:
- Form: NA;
- Parties: NA;
- Incentives: none;
- Co-interventions: yes.
Experimental group: teaching joint protection techniques, including contracting as part of a goal-setting and
self-monitoring process, compared with no intervention.
Control group: later received the same intervention.
Outcomes Use of joint protection techniques at 12 and 24 weeks. Measures of pain, functional disability, grip strength,
self-efficacy and helplessness.
Notes
Allocation concealment B – Unclear
Study Hoelscher 1986
Methods Randomised controlled trial with four groups, one of the groups using contracts.
Participants Country: USA.
Setting: NA.
Health problem: hypertension.
Recruitment: adverts.
Participants: adults (n=50).
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Characteristics of included studies (Continued )
Interventions Contract features:
- Form: written;
- Parties: patients-carers;
- Incentives: other;
- Co-interventions: yes.
Group 1: Group relaxation training plus contingency contracting. The contract specified daily or weekly
consequences to be given by the participant’s spouse for practicing relaxation exercises.
Group 2: Individual relaxation training.
Group 3: Group relaxation training.
Group 4: Waiting list.
Outcomes Compliance with relaxation exercises and changes in blood pressure at week 5 to 6 and week 9 to 10.
Notes
Allocation concealment B – Unclear
Study Keane 1984
Methods Randomised controlled trial with three groups.
Participants Country: USA.
Setting: Hospital (Veterans Administration Medical Center - Alcohol Dependence Treatment Program).
Health problem: addictions (alcohol).
Recruitment: health system.
Participants: men (n=25).
Interventions Contract features:
- Form: written;
- Parties: tripartite;
- Incentives: other;
- Co-interventions: yes.
Group 1: Contracting and recording - patients took their daily medication in front of a significant other and
they both recorded, signed and dated it on a standard form.
Group 2: Contracting and recording plus significant other given instructions for reinforcement.
Group 3: Explanations in relation to disulfiram (Antabuse); phone calls to check on use and aid in resolving
difficulties.
Outcomes Participants who collected monthly prescriptions for disulfiram (Antabuse) for 3 months. Participants whose
significant other reported disulfiram being taken daily at 3 months, percentage of aftercare sessions attended.
Notes
Allocation concealment B – Unclear
Study Lash 1998
Methods Randomised controlled trial with two groups.
Participants Country: USA.
Setting: speciality (Veterans Affairs Medical Center inpatient substance abuse treatment program).
Health problem: addictions (alcohol and drugs).
Recruitment: health system.
Participants: adults (n=40).
Interventions Contract features:
- Form: written;
- Parties: patients-practitioners;
- Incentives: none;
- Co-interventions: yes.
Experimental group: aftercare orientation session plus aftercare participation contract.
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Characteristics of included studies (Continued )
Control group: videotape of motivational speaker on aftercare.
Outcomes Number of aftercare sessions attended.
Notes
Allocation concealment B – Unclear
Study Litzelman 1993
Methods Randomised controlled trial with two groups.
Participants Country: USA.
Setting: PHC.
Health problem: diabetes.
Recruitment: health system.
Participants: adults (n=395).
Interventions Contract features:
- Form: written;
- Parties: patients-practitioners;
- Incentives: none;
- Co-interventions: yes.
Experimental group: education sessions, individually-negotiates footcare contracts and postal reminders
about footcare.
Control group: routine care.
Outcomes Foot lesions at 1 year, and various foot care behaviours.
Notes
Allocation concealment B – Unclear
Study Mayer 1991
Methods Randomised controlled trial with two groups.
Participants Country: USA.
Setting: other.
Health problem: breast self-examination.
Recruitment: adverts.
Participants: female University employees (n=36).
Interventions Contract features:
- Form: written;
- Parties: patients-carers;
- Incentives: deposit;
- Co-interventions: yes.
Experimental group: contract to remind to perform breast self-examination.
Control group: no contracting.
Outcomes Frequency of breast self-examination, and frequency of being prompted.
Notes
Allocation concealment B – Unclear
Study McLean 1973
Methods Randomised controlled trial with two groups.
Participants Country: Canada.
Setting: other.
Health problem: depression.
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Characteristics of included studies (Continued )
Recruitment: health system.
Participants: adults aged 20-55 and their spouses (n=20).
Interventions Contract features:
- Form: NA;
- Parties: patients-carers;
- Incentives: other;
- Co-interventions: yes.
Experimental group: contract between husband and wife relating to the communication between themselves,
training in social learning principles, and course in immediate feedback.
Control group: usual care and monitoring the course of depression.
Outcomes Target communication behaviours and negative reactions.
Notes
Allocation concealment B – Unclear
Study Morgan 1988
Methods Randomised controlled trial with two groups.
Participants Country: USA.
Setting: speciality.
Health problem: diabetes.
Recruitment: health system and adverts.
Participants: adults (n=60).
Interventions Contract features:
- Form: written;
- Parties: patients-carers;
- Incentives: other;
- Co-interventions: yes.
Experimental group: educational programme on the management of diabetes, with weekly contracts for
behaviour change in exchange for reinforcers such as flowers or lottery tickets.
Control group: similar education programme without contracts.
Outcomes Change in weight, fasting blood glucose, glycosylated haemoglobin and knowledge score at week 8.
Notes
Allocation concealment B – Unclear
Study Morisky 2001
Methods Randomised controlled trial with four groups.
Participants Country: USA.
Setting: PHC.
Health problem: tuberculosis.
Recruitment: health system.
Participants: adolescents (n=794) and their parents.
Interventions Contract features:
- Form: NA;
- Parties: patients-carers;
- Incentives: other;
- Co-interventions: no.
Group 1: Contingency contracts negotiated between adolescents and their parents where the parent provide
an incentive in return for adolescent adhering to prescribed medication.
Group 2: Contingency contracts plus peer counselling.
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Characteristics of included studies (Continued )
Group 3: Peer counselling only.
Group 4: Routine care.
Outcomes Completion of treatment.
Notes
Allocation concealment B – Unclear
Study Murphy 1982
Methods Randomised controlled trial with a 2 x 2 factorial design plus 2 control groups.
Participants Country: USA.
Setting: other.
Health problem: overweight.
Recruitment: adverts.
Participants: adults (n=97 couples).
Interventions Contract features:
- Form: written;
- Parties: patients-carers;
- Incentives: tokens;
- Co-interventions: yes.
Group 1: Attended weight loss education sessions alone and made contingency contracts selecting their own
punishments and rewards for specified weight loss behaviours.
Group 2: Attended weight loss education sessions alone and made contingency contracts as for group 1 but
agreed and signed by both themselves and their spouse.
Group 3: Attended weight loss education sessions with their spouse and made contingency contracts selecting
their own punishments and rewards for specified weight loss behaviours.
Group 4: Attended weight loss education sessions alone and made contingency contracts agreed and signed
by both themselves and their spouse.
Group 5: Attendance at a weight-loss support group.
Group 6: No intervention.
Outcomes Mean weight loss, percentage excess weight loss, and weight reduction index at 10 weeks.
Notes
Allocation concealment B – Unclear
Study O’Farrell 1984
Methods Randomised controlled trial with three groups.
Participants Country: USA.
Setting: other.
Health problem: addictions (alcohol).
Recruitment: health system.
Participants: men (n=36) and their wives.
Interventions Contract features:
- Form: written;
- Parties: tripartite;
- Incentives: none;
- Co-interventions: yes.
Group 1: Contract: The husband agrees to take disulfiram (Antabuse) daily and the wife observes and
records it. In return she agrees not to mention any past drinking or any fears about future drinking. Couple
counselling stressing goodwill and caring behaviours.
Group 2: Couple counselling with catharsis, ventilation, sharing of feelings.
Group 3: No marital treatment.
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Characteristics of included studies (Continued )
Outcomes Satisfaction with the programme, ability to solve problems and adherence to sessions.
Notes
Allocation concealment B – Unclear
Study Ossip-Klein 1984
Methods Cluster randomised controlled trial with two groups.
Participants Country: USA.
Setting: other.
Health problem: addictions (alcohol).
Recruitment: health system.
Participants: adult male (n=50).
Interventions Contract features:
- Form: written;
- Parties: patients-carers;
- Incentives: other;
- Co-interventions: no.
Experimental group: contractwith a significant other or self, agreeing to post a prompt calendar in a prominent
place, attend aftercare sessions and telephone at least an hour in advance if unable to attend aftercare.
Control group: no contracts or prompt calendars.
Outcomes Attendance at aftercare sessions.
Notes
Allocation concealment A – Adequate
Study Piotrowski 1999
Methods Randomised controlled trial with two groups.
Participants Country: USA.
Setting: speciality.
Health problem: addictions (opiate).
Recruitment: other.
Participants: adults (n=102).
Interventions Contract features:
- Form: written;
- Parties: patients-practitioners;
- Incentives: tokens;
- Co-interventions: no.
Experimental group: contracts using monetary (in the form of tokens) rewards for abstinence from illicit
drugs and alcohol as assessed in random tests.
Control group: random tests and feedback only.
Outcomes Number of substance free samples and longest period of abstinence at different follow up times. Costs.
Notes
Allocation concealment B – Unclear
Study Poole 1981
Methods Randomised controlled trial with four groups.
Participants Country: Australia.
Setting: NA.
Health problem: addictions (smoking).
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Characteristics of included studies (Continued )
Recruitment: adverts.
Participants: adults under the age of 50 (n=75).
Interventions Contract features.
- Form: written;
- Parties: patients-carers;
- Incentives: deposit;
- Co-interventions: yes.
Group 1: Rapid smoking sessions.
Group 2: Rapid smoking sessions plus relaxation training.
Group 3: Rapid smoking, relaxation and contingency contracting; drawn up between patient and significant
other to reinforce patients’ not smoking.
Group 4: Contingent rapid smoking; patients who smoked were required to attend extra rapid smoking
sessions.
Outcomes Abstinence from smoking from 1 week to 12 months after treatment.
Notes
Allocation concealment B – Unclear
Study Putnam 1994
Methods Randomised controlled trial with two groups.
Participants Country: USA.
Setting: other.
Health problem: acute infections.
Recruitment: health system.
Participants: students aged 18-26 (n=110).
Interventions Contract features:
- Form: written;
- Parties: self-commitment;
- Incentives: none;
- Co-interventions: no.
Experimental group: patients signed commitment to take all their medication.
Control group: usual care.
Outcomes Adherence based on pill counts, self-reported adherence and additional prescriptions received.
Notes
Allocation concealment B – Unclear
Study Schulman 1980
Methods Randomised controlled trial with three groups.
Participants Country: USA.
Setting: hospital.
Health problem: hypertension.
Recruitment: health system.
Participants: adults (n=105).
Interventions Contract features:
- Form: written;
- Parties: self-commitment;
- Incentives: other;
- Co-interventions: yes.
Group 1: Education booklet plus contingency contracts with behavioural goals; patients received an agreed
reward from a nurse for certain behaviours.
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Characteristics of included studies (Continued )
Group 2: Education booklet.
Group 3: Usual care only.
Outcomes Active patient orientation score, indices of resources score and facts index.
Notes
Allocation concealment B – Unclear
Study Swain 1981
Methods Randomised controlled trial with three groups.
Participants Country: USA.
Setting: PHC.
Health problem: hypertension.
Recruitment: health system.
Participants: adults (n=115).
Interventions Contract features:
- Form: written;
- Parties: patients-carers;
- Incentives: other;
- Co-interventions: yes.
Group 1: Education booklet plus contingency contracts with behavioural goals; patients received an agreed
reward from a nurse for reaching agreed goals.
Group 2: Education booklet.
Group 3: Usual care only.
Outcomes Change in knowledge score, number of participants discontinuing treatment, diastolic blood pressure.
Notes
Allocation concealment B – Unclear
Study Vinson 2000
Methods Randomised controlled trial.
Participants Country: USA.
Setting: PHC.
Health problem: addictions (alcohol).
Recruitment: health system.
Participants: adult patients (n=80).
Interventions Contract features:
- Form: written;
- Parties: tripartite;
- Incentives: none;
- Co-interventions: no.
Experimental group: contract for changing drinking behaviour produced using options within a computer
programme, reviewed by a physician and signed by both the physician and the patient.
Control group: screening and baseline assessment.
Outcomes Alcohol Use Disorders Identification Test (AUDIT) and Addiction Severity Index (ASI) scores at 12 months.
Notes
Allocation concealment A – Adequate
Study Wurtele 1980
Methods Randomised controlled trial with three groups.
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Participants Country: USA.
Setting: other.
Health problem: tuberculosis.
Recruitment: adverts.
Participants: students (n=1946).
Interventions Contract features:
- Form: written;
- Parties: patients-practitioners;
- Incentives: none;
- Co-interventions: no.
Group 1: participants were asked for both verbal and written commitment to return.
Group 2: participants were asked for their verbal commitment to return for skin-test reading in 48 hours.
Group 3: participants were told to return to have skin test read 48 hours later.
Outcomes Number attending for skin test reading.
Notes
Allocation concealment B – Unclear
NA: information not available; PHC: Primary Health Care. The number of participants reflects the number entering the studies, which may differ from
the number analysed.
Parties are categorised as healthcare practitioners, participants/patients, and carers (including peers and significant others). Tripartite contracts involve
patients, carers and healthcare practitioners.
Characteristics of excluded studies
Study Reason for exclusion
Azrin 1994 Not an RCT
Becona 1997 Not an RCT
Bishai 2003 Not an RCT
Black 1983 Compares two types of contracts
Bowers 1987 Compares two types of contracts
Brubaker 2003 Not an RCT
Budney 2001 No comparison group
Bull 2000 Not an RCT
Calsyn 1996 Does not assess the effects of contracts
Capelli 1990 Not an RCT (see notes)
Christensen 1995 Not an RCT
Coelho 1985 No data on outcomes comparing intervention and control
Cottler 1998 Not an RCT. Not a contract intervention
Cummings 1981 Not an RCT
Davis 1995 Compares two types of contracts
Donaldson 1997 Not an RCT
Epstein 2001 Not a contract intervention
Feeney 2001 Not an RCT
Feeney 2002 Not an RCT
Fleming 1997 Not a contract intervention
Hamilton 1993 Not a contract intervention
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Characteristics of excluded studies (Continued )
Harzer 2000 Not an RCT
Hennig 1998 Not a contract intervention. No appropriate outcomes
Jeffery 1983 Compares two types of contracts; no control group
Jeffery 1984 Not an RCT (same study as Jeffery 1983)
Jeffrey 1975 Not a contract intervention
Johnson 1991 Not an RCT
Jones 1993 Not an RCT
Kim 1991 Not an RCT
Laidlaw 1999 Not an RCT
Leslie 1991 Not an RCT
Lierman 1994 No data on outcomes comparing contracts with control
Lowe 1997 No appropriate outcomes
Messina 2003 Not a contract intervention
Miller 1995 Not an RCT
Napolitan 1999 Not an RCT
Neale 1991 Not an RCT
Neuberger 1993 Not an RCT
Norton 1980 Not a contract intervention, no appropriate outcomes
Ordman 1985 Not a contract intervention
Pantalon 2001 Not an RCT
Paxton 1980 Not an RCT
Radojevic 1992 Not an RCT
Resnicow 1997 Only data on outcomes for the intervention group
Sagawa 2003 Not an RCT
Sand 1974 No data on outcomes
Saxon 1993 Not an RCT
Schinke 1976 Not a contract intervention
Solanto 1994 Comparing two types of contracts
Stuart 1976 Not a health related topic
Toseland 1983 Not an RCT
Tusel 1994 Not enough data on outcomes, no response to attempted contact with author(s)
Ureda 1980 Two types of contracts
Van Dover 1985 Not enough data on outcomes, no response to attempted contact with author(s)
Villano 2002 Not an RCT
Wysocki 1989 Not an RCT
Zandee 1996 Not an RCT
For additional information about the exclusion of studies other than RCTs, see the ’Notes’ section.
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A D D I T I O N A L T A B L E S
Table 01. Assessment of methodological quality
Study
Randomi-
sation
method
Allocat.
conceal-
ment
Baseline
measures
Practition-
ers blind
Partici-
pants blind
Outcomes
blind Follow up
Consumers
involved
Aragona
1975
Unclear Unclear Adequate Unclear Unclear Unclear Adequate Unclear
Barrera
1977
Unclear Unclear Unclear Unclear Unclear Unclear Unclear Unclear
Binstock
1988
Unclear Unclear Adequate Unclear Unclear Unclear Adequate Unclear
Brockway
1977
Unclear Unclear Inadequate Unclear Unclear Unclear Adequate Unclear
Burkhart
2002
Adequate Unclear Inadequate Unclear Unclear Unclear Adequate Unclear
Calsyn 1994 Unclear Unclear Inadequate Unclear Unclear Unclear Adequate Unclear
Claydon
1997
Unclear Unclear Adequate Inadequate Adequate Adequate Adequate Unclear
Curry 1988 Adequate Unclear Unclear Unclear Unclear Unclear Adequate Unclear
Flanders
1985
Unclear Unclear Unclear Unclear Unclear Unclear Unclear Unclear
Craighead
1989
Unclear Unclear Adequate Unclear Unclear Unclear Inadequate Unclear
Haber 1993 Unclear Unclear Adequate Inadequate Adequate Inadequate Adequate Unclear
Hammond
1999
Unclear Unclear Inadequate Inadequate Adequate Adequate Inadequate Unclear
Hoelscher
1986
Unclear Unclear Adequate Unclear Unclear Adequate Adequate Unclear
Keane 1984 Unclear Unclear Unclear Unclear Unclear Unclear Adequate Unclear
Lash 1998 Unclear Unclear Adequate Unclear Unclear Unclear Adequate Unclear
Litzelman
1993
Unclear Unclear Inadequate Adequate Unclear Adequate Adequate Unclear
Mayer 1991 Unclear Unclear Inadequate Unclear Unclear Unclear Adequate Unclear
McLean
1973
Unclear Unclear Adequate Unclear Unclear Unclear Unclear Unclear
Morgan
1988
Unclear Unclear Unclear Unclear Unclear Unclear Unclear Unclear
Morisky
2001
Unclear Unclear Adequate Unclear Unclear Unclear Adequate Unclear
Murphy
1982
Unclear Unclear Adequate Unclear Unclear Unclear Inadequate Unclear
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Table 01. Assessment of methodological quality (Continued )
Study
Randomi-
sation
method
Allocat.
conceal-
ment
Baseline
measures
Practition-
ers blind
Partici-
pants blind
Outcomes
blind Follow up
Consumers
involved
O’Farrell
1984
Unclear Unclear Adequate Unclear Unclear Unclear Unclear Unclear
Ossip-Klein
1984
Unclear Adequate Adequate Adequate Unclear Unclear Adequate Unclear
Piotrowski
1999
Unclear Unclear Adequate Unclear Unclear Unclear Adequate Unclear
Poole 1981 Unclear Unclear Adequate Unclear Unclear Unclear Adequate Unclear
Putnam
1994
Unclear Unclear Adequate Adequate Unclear Unclear Inadequate Unclear
Schulman
1980
Unclear Unclear Unclear Unclear Unclear Unclear Unclear Unclear
Swain 1981 Unclear Unclear Adequate Adequate Unclear Unclear Unclear Unclear
Vinson
2000
Adequate Adequate Inadequate Inadequate Unclear Adequate Adequate Unclear
Wurtele
1980
Unclear Unclear Adequate Unclear Unclear Adequate Adequate Unclear
38Contracts between patients and healthcare practitioners for improving patients’ adherence to treatment, prevention and health
promotion activities (Review)
Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd
Table 02. ADDICTIONS: Outcomes for each individual study and statistical significance
Study
Number
analysed Contract details Co-intervention Control desc. Control details
Outcomes: fav.
int.
Outcomes: fav
contr.
Outcomes: no
diff.
Brockway 1977 27 Eliminate
smoking in two
situations per
week. Subjects
monitored
their smoking
behaviour in
detail / multi-
session smoking
cessation
programme.
Teaching of
relaxation.
Information
on the effects
of stopping
smoking.
Yes Routine No smoking
cessation
programme.
Mean number
of cigarettes
smoked at end of
treatment, 3 and
6 months follow
up.
Mean number of
cigarettes smoked
at 12 months
follow up.
Calsyn 1994 353 Contracts written
depending on
achievement of
abstinence goals.
- Group (1)
Medication only:
saw counsellor
to complete
standard
treatment.
- Group (2)
Standard:
counselling
sessions and
optional drug
education classes.
- Group (3)
Enhanced: as
Yes Complex Three groups
(4), (5) and (6),
replicating the
intervention
conditions
but without
contingency
contracting.
- Time with
positive urine
analyses for
opiates (groups 1
versus 4).
- Positive urine
analyses after 9
week stabilisation
period for
opiates.
- Positive urine
analyses after
18 months, (a)
regardless of the
substance, (b) for
opiates and (c)
for cocaine.
- Time out of
- Discharge rate. - Time with
positive urine
analyses for
cocaine.
- Retention
in treatment
(significance not
reported).
- Positive
urine analyses
after 9 weeks
stabilisation
period for
cocaine.
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Table 02. ADDICTIONS: Outcomes for each individual study and statistical significance (Continued )
Study
Number
analysed Contract details Co-intervention Control desc. Control details
Outcomes: fav.
int.
Outcomes: fav
contr.
Outcomes: no
diff.
per group (2)
plus relapse
prevention skill
training group
and weekly group
treatment.
treatment before
readmission.
Curry 1988 139 Absolute
abstinence /
contingency
contracting.
Yes Complex Relapse
prevention:
cold turkey
withdrawal,
identifying high
risk situations,
etc.
Percentage of
participants
abstinent
(both for all
participants
randomised, and
for only those
who began the
treatment) at
several periods
(post-treatment
up to 1 year).
Keane 1984 25 - Group (1)
Contract /
recording.
- Group (2)
Contract /
recording +
instructions
for positive
reinforcement.
Yes Complex - Group (3)
Explanations
in relation
to disulfiram
(Antabuse);
phone calls to
check on use
of disulfiram
(Antabuse) and
aid in resolving
difficulties.
- Three months
of disulfiram
(Antabuse)
dispensed by the
pharmacy.
- disulfiram
(Antabuse) intake
reported by other
(significance not
reported).
- Aftercare
sessions attended
(significance not
reported).
Lash 1998 40 Aftercare Yes Routine Videotape of - Number Mean number of
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Table 02. ADDICTIONS: Outcomes for each individual study and statistical significance (Continued )
Study
Number
analysed Contract details Co-intervention Control desc. Control details
Outcomes: fav.
int.
Outcomes: fav
contr.
Outcomes: no
diff.
orientation
session plus
aftercare
participation
contract.
motivational
speaker on
aftercare.
of subjects
attending after
care.
- Total sessions
attended.
sessions attended
(significance not
reported).
O’Farrell 1984 36 - Group (1)
Husband takes
disulfiram
(Antabuse). Wife
observes and
records it. In
return she will
not mention any
past drinking or
any fears about
future drinking.
Yes Complex - Group (2)
Interactional
group: catharsis,
ventilation,
sharing of
feelings.
- Group (3) no
treatment.
Satisfaction
outcomes,
ability to solve
problems,
adherence
to sessions
(significance level
not reported).
(Data reported
for group 1 and
group 2 only).
Ossip-Klein
1984
50 Posting the
prompt calendar;
attending
aftercare; calling
the Alcohol
Program if
unable to attend.
No Routine Only telephone
prompt.
Percentage
attendance
aftercare sessions
1, 3, 4 and 6 (6
months).
Percentage
attendance
aftercare session
2, 5, 7 and 8.
Piotrowski 1999 102 Contingency
contracting for
absence of illicit
drugs.
No Routine Random tests
and feedback
only.
Longest period
with continuous
abstinence at 90
to180 days.
- Substance
free samples
(proportion of
subjects).
- Longest period
with continuous
abstinence at 30
to 60 days.
- Longest period
substance free
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Table 02. ADDICTIONS: Outcomes for each individual study and statistical significance (Continued )
Study
Number
analysed Contract details Co-intervention Control desc. Control details
Outcomes: fav.
int.
Outcomes: fav
contr.
Outcomes: no
diff.
samples for
all substances
combined.
- Total costs of
treatment at 1 to
4 months.
Poole 1981 75 Group (1)
Rapid smoking
/ relaxation /
contracting.
Yes Behavioural - Group (2)
Rapid smoking
session.
- Group (3)
Rapid smoking /
relaxation.
- Group (4)
Contingent
Rapid smoking.
- Time remaining
abstinent
(measured by
self-reported
daily cigarette
consumption)
similar between
groups (measured
at any time
period from
1 week to 12
months).
- Cigarette
consumption
compared
with baseline
smoking, from
1 week to 12
months follow
up.
Vinson 2000 69 Produced by the
patient using a
list of options
in a computer
programme.
No Routine Screening
and baseline
assessment.
Change in
Alcohol Use
Disorders
Identification
Test (AUDIT)
scores at 12
months. (Note:
Addiction
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Table 02. ADDICTIONS: Outcomes for each individual study and statistical significance (Continued )
Study
Number
analysed Contract details Co-intervention Control desc. Control details
Outcomes: fav.
int.
Outcomes: fav
contr.
Outcomes: no
diff.
Severity Index
(ASI) scores not
reported for
intervention and
control group
separately).
4
3
C
o
n
tra
c
ts
b
e
tw
e
e
n
p
a
tie
n
ts
a
n
d
h
e
a
lth
c
a
re
p
ra
c
titio
n
e
rs
fo
r
im
p
ro
v
in
g
p
a
tie
n
ts’
a
d
h
e
re
n
c
e
to
tre
a
tm
e
n
t,
p
re
v
e
n
tio
n
a
n
d
h
e
a
lth
p
ro
m
o
tio
n
a
c
tiv
itie
s
(R
e
v
ie
w
)
C
o
p
y
rig
h
t
©
2
0
0
8
T
h
e
C
o
c
h
ra
n
e
C
o
lla
b
o
ra
tio
n
.
P
u
b
lish
e
d
b
y
Jo
h
n
W
ile
y
&
S
o
n
s,
L
td
Table 03. HYPERTENSION: Outcomes for each individual study and statistical significance
Study
Number
analysed Contracts details
Co-
interventions Control desc. Control details
Outcomes: fav
int.
Outcomes: fav
contr.
Outcomes: no
diff.
Binstock 1988 112 - Group (1)
Contracts +
educational
program.
- Group (2)
Contracts +
educational
programme + BP
measurement at
home + calendar
pills.
Yes Educational - Group (3)
Bi-monthly
educational
program.
- Group (4)
Educational + BP
measurement at
home.
- Group (5)
Calendar pills.
Change of blood
pressure from
baseline to 1
year follow up
(not significant
differences
between groups
1, 2, 4 and 5).
Hoelscher 1986 50 - Group (1)
Contracts / group
relaxation.
Yes Complex - Group (2)
Individual
relaxation.
- Group (3)
Group relaxation.
- Group (4)
Waiting list.
Cost-
effectiveness (1
versus 2).
Compliance
with relaxation
practices (1
versus 3).
Blood pressure
reduction at 6
and 10 weeks
(not significant 1
against 3)
Schulman 1980 91 - Group (1)
Contract with
behavioural goals.
Yes Educational - Group (2)
Routine /
education
booklets.
- Group (3)
Routine.
Active Patient
Orientation
scores (see text
for further
explanations).
Availability
of treatment
resources score (1
versus 2 and 3).
Facts related to
the management
of hypertension
(1 versus 3).
(Patients’
perceptions of
the treatment
Facts index (1
versus 2).
4
4
C
o
n
tra
c
ts
b
e
tw
e
e
n
p
a
tie
n
ts
a
n
d
h
e
a
lth
c
a
re
p
ra
c
titio
n
e
rs
fo
r
im
p
ro
v
in
g
p
a
tie
n
ts’
a
d
h
e
re
n
c
e
to
tre
a
tm
e
n
t,
p
re
v
e
n
tio
n
a
n
d
h
e
a
lth
p
ro
m
o
tio
n
a
c
tiv
itie
s
(R
e
v
ie
w
)
C
o
p
y
rig
h
t
©
2
0
0
8
T
h
e
C
o
c
h
ra
n
e
C
o
lla
b
o
ra
tio
n
.
P
u
b
lish
e
d
b
y
Jo
h
n
W
ile
y
&
S
o
n
s,
L
td
Table 03. HYPERTENSION: Outcomes for each individual study and statistical significance (Continued )
Study
Number
analysed Contracts details
Co-
interventions Control desc. Control details
Outcomes: fav
int.
Outcomes: fav
contr.
Outcomes: no
diff.
rationales or facts
the staff shared
with them, and
of the resources
available,
respectively.)
Swain 1981 115 As above Yes Educational As above Change in
knowledge score
(1 versus 2).
Subjects
discontinuing
treatment.
Diastolic
blood pressure
controlled.
4
5
C
o
n
tra
c
ts
b
e
tw
e
e
n
p
a
tie
n
ts
a
n
d
h
e
a
lth
c
a
re
p
ra
c
titio
n
e
rs
fo
r
im
p
ro
v
in
g
p
a
tie
n
ts’
a
d
h
e
re
n
c
e
to
tre
a
tm
e
n
t,
p
re
v
e
n
tio
n
a
n
d
h
e
a
lth
p
ro
m
o
tio
n
a
c
tiv
itie
s
(R
e
v
ie
w
)
C
o
p
y
rig
h
t
©
2
0
0
8
T
h
e
C
o
c
h
ra
n
e
C
o
lla
b
o
ra
tio
n
.
P
u
b
lish
e
d
b
y
Jo
h
n
W
ile
y
&
S
o
n
s,
L
td
Table 04. OVERWEIGHT: Outcomes for each individual study and statistical significance
Study
Number
analysed
Contracts
details Co-intervention Control desc. Control details
Outcomes: fav
int.
Outcomes: fav
contr.
Outcomes: no
diff.
Aragona 1975 12 - Group (1)
Contracts
plus exercise
programme,
nutritional
information,
food diary.
- Group (2) like
Group (1) plus
reinforcement
(deposit).
Yes - Group (3)
Routine
Weight change
from start to end
treatment and at
8 weeks follow
up.
Craighead 1989 62 Group (1)
Contracted
exercise / written
lessons.
Yes Complex Instructions plus
- Group (2)
Supervised
exercise.
- Group (3)
Minimal contact.
- Among
completers of
the 12 week
treatment,
weight loss
measured at 12
weeks (groups 1
versus 3).
- Among
completers of
follow up (1
year), weight loss
measured at 12
weeks (1 versus
3)
- Among
completers of
the 12 week
treatment,
weight loss
measured at 12
weeks (groups 1
versus 2).
- Among
completers of
follow up (1
year), weight loss
measured at 12
weeks (1 versus
2)
- Among
completers of
follow up (1
year), weight loss
measured at 12
months (1 versus
2)
Harvard step test
fitness score pre-
- Among
completers of
follow up (1
year), weight loss
measured at 12
months (1 versus
3).
- Treatment
self-reported as
helpful (group 1
versus 2).
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Table 04. OVERWEIGHT: Outcomes for each individual study and statistical significance (Continued )
Study
Number
analysed
Contracts
details Co-intervention Control desc. Control details
Outcomes: fav
int.
Outcomes: fav
contr.
Outcomes: no
diff.
post group 2
(not significant
in the others).
Murphy 1982 97 - Group (1)
Sessions attended
alone: 1 party
contract.
- Group (2)
Alone: 2 Parties.
- Group (3)
Couple: 1 Party.
- Group (4)
Couple: 2
Parties.
Yes Complex - Group (5)
Support group.
- Group (6)
Waiting list.
Mean weight
loss, percentage
excess weight
loss, weight
reduction index
all at 10 weeks
comparing
groups 1 to 4
versus 5.
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Table 05. MISCELLANEOUS: Outcomes for each individual study and statistical significance
Study
Number
analysed
Contracts
details Co-intervention Control desc. Control details
Outcomes: fav
int.
Outcomes: fav
contr.
Outcomes: no
diff.
Barrera 1977 24 Snake phobia.
- Group (1)
Contract and
self-administered
desentisation.
Yes Routine - Group (2) Self-
administered
systematic
desentisation
(SSD).
- Group
(3) Placebo
bibliographic
programme.
Sessions attended
and time spent
studying the
materials (group
2 versus 1).
Post-test or
follow-up score
of any outcome.
Burkhart 1996 42 Asthma.
Contract for Peak
Expiratory Flow
Rate (PEFR)
monitoring,
reinforcement,
tailoring,
reminders.
Yes Routine Training in using
peak flow meter.
Adherence
to PEFR
monitoring;
asthma episodes.
Claydon 1997 75 Contact lenses.
Teaching
checklist,
complications
poster, care
regimen
video, regimen
poster, booklet,
appointment
reminder,
telephone call.
Contract.
Yes Routine Provision of
contact lenses,
solutions, basic
instructions and
aftercare.
All outcomes
(e.g. washing
hands or rinsing
lenses).
Flanders 1985 42 Acne.
- Group (1)
Non-contingent
contract.
- Group (2)
Yes Complex - Group (3)
Education and
self-monitoring
card. - Group (4)
Waiting list.
Compliance.
Number of acne
lesions.
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Table 05. MISCELLANEOUS: Outcomes for each individual study and statistical significance (Continued )
Study
Number
analysed
Contracts
details Co-intervention Control desc. Control details
Outcomes: fav
int.
Outcomes: fav
contr.
Outcomes: no
diff.
Contingent
contract both
with education +
self monitoring
medication card.
Haber 1993 64 Healthy diet.
Contracts, peer
support group
intervention and
health education
classes.
Yes Educational Health education
classes.
Increase in fibre,
salt limited.
Limiting
fats, sweets;
practice of stress
management
techniques and
exercises.
Hammond 1999 35 Arthritis.
Contracts, Joint
Protection
education group.
Yes Routine No intervention
(later received
active
intervention)
Joint protection
behaviour
score (before
cross-over);
self reported
joint protection
practice.
Joint protection
behaviour score
(after cross-over).
Joint protection
knowledge.
Health related
outcomes.
Litzelman 1993 395 Diabetes.
Contracts and
educational
sessions.
Yes Routine Two health
outcomes (e.g.
ulcers); five
behaviour
outcomes (e.g.
wash feet);
four items
in physician
documentation
(e.g. ulcers
recorded).
Five health
outcomes (e.g.
ingrowing nails);
seven behaviour
outcomes (e.g.
trimmed nails)
and six items
in physician
documentation
(e.g. record of
foot deformities).
Mayer 1991 36 Breast self
examination
(BSE). Contracts,
workshops
Yes Educational Workshops and
mail prompts.
Breast self-
examination
frequency;
frequency of
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Table 05. MISCELLANEOUS: Outcomes for each individual study and statistical significance (Continued )
Study
Number
analysed
Contracts
details Co-intervention Control desc. Control details
Outcomes: fav
int.
Outcomes: fav
contr.
Outcomes: no
diff.
(training on
BSE), prompting
/ reminder
options.
being prompted.
McLean 1973 20 Depression.
Contract related
to husband and
wife behaviour
and training in
social learning
principles, course
in immediate
feedback.
Yes Routine Monitoring of
the course of
their depression,
plus usual care.
Improvement in
target behaviours
at mid treatment,
end treatment
and 3 months
follow up.
Decrease of
negative reaction
at end treatment.
Morgan 1988 60 Diabetes.
Teaching /
contracts.
Yes Educational Formal teaching
plan on diabetes
and diet.
Knowledge score
change from
week 1 to 8.
Weight loss,
fasting blood
glucose and
glycosylated
haemoglobin
decrease in the 8
week period.
Morisky 2001 794 Tuberculosis.
- Group (1) Only
contracts.
- Group (2)
Counselling /
contracts.
Yes Complex - Group (3)
Counselling.
- Group (4)
Routine.
Completion of
treatment.
Putnam 1994 60 Acute
infection. Self-
commitment.
No Routine Usual care. Adherence based
on pill count.
Self-reported
adherence;
additional
prescriptions
received.
Wurtele 1980 1946 Tuberculosis.
- Group
No Routine - Group
(2) Verbal
Compliance:
group 1 better
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Table 05. MISCELLANEOUS: Outcomes for each individual study and statistical significance (Continued )
Study
Number
analysed
Contracts
details Co-intervention Control desc. Control details
Outcomes: fav
int.
Outcomes: fav
contr.
Outcomes: no
diff.
(1) Written
and verbal
commitment to
return for the
skin test.
commitment.
- Group (3) No
commitment.
than 2, and 2
better than 3.
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A N A L Y S E S
Comparison 01. Contracts versus control in addictions
Outcome title
No. of
studies
No. of
participants Statistical method Effect size
01 Positive Urine Analysis at 18
months post-treatment entry
Weighted Mean Difference (Fixed) 95% CI Totals not selected
02 Substance free samples Weighted Mean Difference (Fixed) 95% CI Totals not selected
03 Healthcare costs (USD x 1,000) Weighted Mean Difference (Fixed) 95% CI Totals not selected
04 Longest period of abstinence
(days)
Weighted Mean Difference (Fixed) 95% CI Totals not selected
05 Aftercare sessions attended Weighted Mean Difference (Fixed) 95% CI Totals not selected
06 Participants who attended
aftercare sessions
Odds Ratio (Fixed) 95% CI Totals not selected
07 Participants abstinent from
smoking at several times after
treatment
Odds Ratio (Fixed) 95% CI Totals not selected
Comparison 02. Contracts versus control (supervised exercise or minimal care) in weight control
Outcome title
No. of
studies
No. of
participants Statistical method Effect size
01 Weight loss in completers of
treatment at 12 weeks
Weighted Mean Difference (Fixed) 95% CI Totals not selected
02 Weight loss in completers of
treatment and follow-up at 12
months
Weighted Mean Difference (Fixed) 95% CI Totals not selected
Comparison 03. Contracts versus control in lower limbs care in diabetes patients
Outcome title
No. of
studies
No. of
participants Statistical method Effect size
01 Physician documentation of
findings about diabetes-related
lesions
Odds Ratio (Fixed) 95% CI Totals not selected
Comparison 04. Contracts versus control in tuberculosis care
Outcome title
No. of
studies
No. of
participants Statistical method Effect size
01 Subjects completing care Odds Ratio (Fixed) 95% CI Totals not selected
Comparison 05. Contract versus control in depression
Outcome title
No. of
studies
No. of
participants Statistical method Effect size
01 Changes of target behaviours at
various stages compared to pre-
treatment (score)
Weighted Mean Difference (Fixed) 95% CI Totals not selected
52Contracts between patients and healthcare practitioners for improving patients’ adherence to treatment, prevention and health
promotion activities (Review)
Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd
Comparison 06. Contract versus control in adherence to antibiotics for acute infections
Outcome title
No. of
studies
No. of
participants Statistical method Effect size
01 Subjects having received
additional prescriptions
Odds Ratio (Fixed) 95% CI Totals not selected
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G R A P H S A N D O T H E R T A B L E S
Analysis 01.01. Comparison 01 Contracts versus control in addictions, Outcome 01 Positive Urine Analysis at
18 months post-treatment entry
Review: Contracts between patients and healthcare practitioners for improving patients’ adherence to treatment, prevention and health promotion activities
Comparison: 01 Contracts versus control in addictions
Outcome: 01 Positive Urine Analysis at 18 months post-treatment entry
Study Contracts Control Weighted Mean Difference (Fixed) Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI 95% CI
01 Any substance
Calsyn 1994 176 57.80 (25.40) 177 67.20 (26.30) -9.40 [ -14.79, -4.01 ]
02 Opiates
Calsyn 1994 176 37.40 (25.30) 177 43.80 (29.30) -6.40 [ -12.11, -0.69 ]
03 Cocaine
Calsyn 1994 176 37.50 (30.20) 177 44.30 (33.80) -6.80 [ -13.49, -0.11 ]
-100.0 -50.0 0 50.0 100.0
Favours contracts Favours control
Analysis 01.02. Comparison 01 Contracts versus control in addictions, Outcome 02 Substance free samples
Review: Contracts between patients and healthcare practitioners for improving patients’ adherence to treatment, prevention and health promotion activities
Comparison: 01 Contracts versus control in addictions
Outcome: 02 Substance free samples
Study Contracts Control Weighted Mean Difference (Fixed) Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI 95% CI
01 Substance free samples after 120 days of treatment
Piotrowski 1999 51 28.50 (41.20) 51 16.30 (28.40) 12.20 [ -1.53, 25.93 ]
-100.0 -50.0 0 50.0 100.0
Favours control Favours contracts
54Contracts between patients and healthcare practitioners for improving patients’ adherence to treatment, prevention and health
promotion activities (Review)
Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd
Analysis 01.03. Comparison 01 Contracts versus control in addictions, Outcome 03 Healthcare costs (USD x
1,000)
Review: Contracts between patients and healthcare practitioners for improving patients’ adherence to treatment, prevention and health promotion activities
Comparison: 01 Contracts versus control in addictions
Outcome: 03 Healthcare costs (USD x 1,000)
Study Contracts Control Weighted Mean Difference (Fixed) Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI 95% CI
01 1 to 4 months post-treatment
Piotrowski 1999 22 0.40 (0.78) 23 1.33 (2.84) -0.93 [ -2.14, 0.28 ]
02 1 month post-treatment
Piotrowski 1999 22 0.09 (0.30) 23 0.30 (1.00) -0.21 [ -0.64, 0.22 ]
03 2 months post-treatment
Piotrowski 1999 22 0.09 (0.25) 23 0.32 (1.25) -0.23 [ -0.75, 0.29 ]
04 3 months post-treatment
Piotrowski 1999 22 0.11 (0.30) 23 0.11 (0.09) 0.0 [ -0.13, 0.13 ]
05 4 month post-treatment
Piotrowski 1999 22 0.11 (0.32) 23 0.60 (1.83) -0.49 [ -1.25, 0.27 ]
-10.0 -5.0 0 5.0 10.0
Favours contracts Favours control
Analysis 01.04. Comparison 01 Contracts versus control in addictions, Outcome 04 Longest period of
abstinence (days)
Review: Contracts between patients and healthcare practitioners for improving patients’ adherence to treatment, prevention and health promotion activities
Comparison: 01 Contracts versus control in addictions
Outcome: 04 Longest period of abstinence (days)
Study Contracts Control Weighted Mean Difference (Fixed) Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI 95% CI
01 Continuous abstinence at 30 days post treatment
Piotrowski 1999 51 1.88 (2.80) 51 1.51 (2.10) 0.37 [ -0.59, 1.33 ]
02 Continuous abstinence at 60 days post treatment
Piotrowski 1999 51 4.12 (6.30) 51 2.22 (3.20) 1.90 [ -0.04, 3.84 ]
03 Continuous abstinence at 90 days post treatment
Piotrowski 1999 51 5.80 (9.00) 51 2.78 (4.00) 3.02 [ 0.32, 5.72 ]
04 Continuous abstinence at 120 days post treatment
Piotrowski 1999 51 7.59 (11.80) 51 3.29 (5.30) 4.30 [ 0.75, 7.85 ]
05 Continuous abstinence at 150 days post treatment
Piotrowski 1999 51 8.22 (12.90) 51 3.35 (5.40) 4.87 [ 1.03, 8.71 ]
-10.0 -5.0 0 5.0 10.0
Favours control Favours contracts (Continued . . . )
55Contracts between patients and healthcare practitioners for improving patients’ adherence to treatment, prevention and health
promotion activities (Review)
Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd
(. . . Continued)
Study Contracts Control Weighted Mean Difference (Fixed) Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI 95% CI
06 Continuous abstinence at 180 days post treatment
Piotrowski 1999 51 8.45 (13.60) 51 3.35 (5.40) 5.10 [ 1.08, 9.12 ]
07 Substance free samples for alcohol
Piotrowski 1999 33 6.60 (12.50) 36 3.40 (5.30) 3.20 [ -1.40, 7.80 ]
08 Substance free samples for amphetamines
Piotrowski 1999 5 10.80 (15.90) 8 1.50 (2.00) 9.30 [ -4.71, 23.31 ]
09 Substance free samples for barbiturates
Piotrowski 1999 7 12.80 (7.30) 4 6.90 (7.70) 5.90 [ -3.38, 15.18 ]
10 Substance free samples for benzodiazepines
Piotrowski 1999 23 10.40 (13.70) 22 3.00 (5.20) 7.40 [ 1.39, 13.41 ]
11 Substance free samples for cocaine
Piotrowski 1999 44 6.80 (11.90) 38 3.90 (5.90) 2.90 [ -1.09, 6.89 ]
12 Substance free samples for marijuana
Piotrowski 1999 26 6.90 (10.60) 22 2.10 (2.60) 4.80 [ 0.58, 9.02 ]
-10.0 -5.0 0 5.0 10.0
Favours control Favours contracts
Analysis 01.05. Comparison 01 Contracts versus control in addictions, Outcome 05 Aftercare sessions
attended
Review: Contracts between patients and healthcare practitioners for improving patients’ adherence to treatment, prevention and health promotion activities
Comparison: 01 Contracts versus control in addictions
Outcome: 05 Aftercare sessions attended
Study Contracts Control Weighted Mean Difference (Fixed) Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI 95% CI
Lash 1998 20 3.00 (3.10) 20 1.40 (2.30) 1.60 [ -0.09, 3.29 ]
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Analysis 01.06. Comparison 01 Contracts versus control in addictions, Outcome 06 Participants who
attended aftercare sessions
Review: Contracts between patients and healthcare practitioners for improving patients’ adherence to treatment, prevention and health promotion activities
Comparison: 01 Contracts versus control in addictions
Outcome: 06 Participants who attended aftercare sessions
Study Contracts Control Odds Ratio (Fixed) Odds Ratio (Fixed)
n/N n/N 95% CI 95% CI
01 At least one aftercare session
Lash 1998 14/20 8/20 3.50 [ 0.94, 12.97 ]
02 Session one
Ossip-Klein 1984 18/25 9/25 4.57 [ 1.38, 15.11 ]
03 Session two
Ossip-Klein 1984 15/25 9/25 2.67 [ 0.85, 8.37 ]
04 Session three
Ossip-Klein 1984 14/25 7/25 3.27 [ 1.01, 10.62 ]
05 Session four
Ossip-Klein 1984 17/25 9/25 3.78 [ 1.17, 12.19 ]
06 Session five
Ossip-Klein 1984 12/25 7/25 2.37 [ 0.73, 7.68 ]
07 Session six
Ossip-Klein 1984 12/25 4/25 4.85 [ 1.29, 18.25 ]
08 Sessions seven
Ossip-Klein 1984 11/25 5/25 3.14 [ 0.89, 11.06 ]
09 Session eight
Ossip-Klein 1984 6/25 6/25 1.00 [ 0.27, 3.66 ]
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Analysis 01.07. Comparison 01 Contracts versus control in addictions, Outcome 07 Participants abstinent
from smoking at several times after treatment
Review: Contracts between patients and healthcare practitioners for improving patients’ adherence to treatment, prevention and health promotion activities
Comparison: 01 Contracts versus control in addictions
Outcome: 07 Participants abstinent from smoking at several times after treatment
Study Contracts Control Odds Ratio (Fixed) Odds Ratio (Fixed)
n/N n/N 95% CI 95% CI
01 One week
Poole 1981 12/18 36/57 1.17 [ 0.38, 3.57 ]
02 One month
Poole 1981 9/18 26/57 1.19 [ 0.41, 3.44 ]
03 Two months
Poole 1981 10/18 24/57 1.72 [ 0.59, 5.00 ]
04 Three months
Poole 1981 6/18 21/57 0.86 [ 0.28, 2.62 ]
05 Six months
Poole 1981 6/18 14/57 1.54 [ 0.49, 4.85 ]
06 Twelve months
Poole 1981 4/18 11/50 1.01 [ 0.28, 3.71 ]
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Analysis 02.01. Comparison 02 Contracts versus control (supervised exercise or minimal care) in weight
control, Outcome 01 Weight loss in completers of treatment at 12 weeks
Review: Contracts between patients and healthcare practitioners for improving patients’ adherence to treatment, prevention and health promotion activities
Comparison: 02 Contracts versus control (supervised exercise or minimal care) in weight control
Outcome: 01 Weight loss in completers of treatment at 12 weeks
Study Contracts Control Weighted Mean Difference (Fixed) Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI 95% CI
01 Weight loss (pounds) measured at 12 weeks. Control: minimal care
Craighead 1989 14 8.10 (1.40) 11 4.60 (1.50) 3.50 [ 2.35, 4.65 ]
04 Weight loss (pounds) measured at 12 weeks. Control: supervised exercise
Craighead 1989 14 8.10 (1.40) 17 11.00 (1.20) -2.90 [ -3.83, -1.97 ]
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Analysis 02.02. Comparison 02 Contracts versus control (supervised exercise or minimal care) in weight
control, Outcome 02 Weight loss in completers of treatment and follow-up at 12 months
Review: Contracts between patients and healthcare practitioners for improving patients’ adherence to treatment, prevention and health promotion activities
Comparison: 02 Contracts versus control (supervised exercise or minimal care) in weight control
Outcome: 02 Weight loss in completers of treatment and follow-up at 12 months
Study Contracts Control Weighted Mean Difference (Fixed) Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI 95% CI
01 Weight loss (pounds) measured at 12 weeks. Control: minimal care
Craighead 1989 13 8.40 (1.40) 10 3.50 (1.60) 4.90 [ 3.65, 6.15 ]
02 Weight loss (pounds) measured at 12 weeks. Control: supervised exercise
Craighead 1989 13 8.40 (1.40) 15 11.90 (1.30) -3.50 [ -4.51, -2.49 ]
03 Weight loss (pounds) measured at 1 year after the end of treatment. Control: minimal care
Craighead 1989 13 4.30 (1.50) 10 4.20 (1.70) 0.10 [ -1.23, 1.43 ]
04 Weight loss (pounds) measured at 1 year after the end of treatment. Control: supervised exercise
Craighead 1989 13 4.30 (1.50) 15 10.60 (1.30) -6.30 [ -7.35, -5.25 ]
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Analysis 03.01. Comparison 03 Contracts versus control in lower limbs care in diabetes patients, Outcome 01
Physician documentation of findings about diabetes-related lesions
Review: Contracts between patients and healthcare practitioners for improving patients’ adherence to treatment, prevention and health promotion activities
Comparison: 03 Contracts versus control in lower limbs care in diabetes patients
Outcome: 01 Physician documentation of findings about diabetes-related lesions
Study Contracts Control Odds Ratio (Fixed) Odds Ratio (Fixed)
n/N n/N 95% CI 95% CI
01 Ulcers
Litzelman 1993 44/185 22/198 2.50 [ 1.43, 4.36 ]
02 Pulse examination
Litzelman 1993 17/185 6/198 3.24 [ 1.25, 8.40 ]
03 Dry or cracked skin
Litzelman 1993 16/185 4/198 4.59 [ 1.51, 14.00 ]
04 Calluses or corns
Litzelman 1993 12/185 2/198 6.80 [ 1.50, 30.80 ]
05 Fungal infection
Litzelman 1993 6/185 1/198 6.60 [ 0.79, 55.38 ]
06 Ingrown nails
Litzelman 1993 5/185 1/198 5.47 [ 0.63, 47.29 ]
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(. . . Continued)
Study Contracts Control Odds Ratio (Fixed) Odds Ratio (Fixed)
n/N n/N 95% CI 95% CI
07 Improperly trimmed nails
Litzelman 1993 4/185 1/198 4.35 [ 0.48, 39.31 ]
08 Foot or leg cellulitis
Litzelman 1993 5/185 3/198 1.81 [ 0.43, 7.66 ]
09 Foot deformities
Litzelman 1993 3/185 2/198 1.62 [ 0.27, 9.78 ]
10 Sensory examination
Litzelman 1993 9/185 5/198 1.97 [ 0.65, 6.00 ]
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Analysis 04.01. Comparison 04 Contracts versus control in tuberculosis care, Outcome 01 Subjects
completing care
Review: Contracts between patients and healthcare practitioners for improving patients’ adherence to treatment, prevention and health promotion activities
Comparison: 04 Contracts versus control in tuberculosis care
Outcome: 01 Subjects completing care
Study Contracts Control Odds Ratio (Fixed) Odds Ratio (Fixed)
n/N n/N 95% CI 95% CI
01 Control: counseling
Morisky 2001 152/199 151/188 0.79 [ 0.49, 1.29 ]
02 Control: combined intervention
Morisky 2001 152/199 162/191 0.58 [ 0.35, 0.97 ]
03 Control: routine care
Morisky 2001 152/199 147/189 0.92 [ 0.58, 1.48 ]
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Analysis 05.01. Comparison 05 Contract versus control in depression, Outcome 01 Changes of target
behaviours at various stages compared to pre-treatment (score)
Review: Contracts between patients and healthcare practitioners for improving patients’ adherence to treatment, prevention and health promotion activities
Comparison: 05 Contract versus control in depression
Outcome: 01 Changes of target behaviours at various stages compared to pre-treatment (score)
Study Contracts Control Weighted Mean Difference (Fixed) Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI 95% CI
01 At mid treatment
McLean 1973 10 0.90 (0.65) 10 0.37 (0.45) 0.53 [ 0.04, 1.02 ]
02 At end treatment
McLean 1973 10 1.12 (0.70) 10 0.17 (0.45) 0.95 [ 0.43, 1.47 ]
03 At 3 months follow-up
McLean 1973 10 1.12 (0.70) 10 0.43 (0.43) 0.69 [ 0.18, 1.20 ]
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Analysis 06.01. Comparison 06 Contract versus control in adherence to antibiotics for acute infections,
Outcome 01 Subjects having received additional prescriptions
Review: Contracts between patients and healthcare practitioners for improving patients’ adherence to treatment, prevention and health promotion activities
Comparison: 06 Contract versus control in adherence to antibiotics for acute infections
Outcome: 01 Subjects having received additional prescriptions
Study Contracts Control Odds Ratio (Fixed) Odds Ratio (Fixed)
n/N n/N 95% CI 95% CI
Putnam 1994 4/30 6/30 0.62 [ 0.15, 2.45 ]
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